Tissue-specific	O
regulation	O
of	O
the	O
ecto-5'-nucleotidase	B-DNA
promoter	I-DNA
.	O

Role	O
of	O
the	O
camp	B-DNA
response	I-DNA
element	I-DNA
site	I-DNA
in	O
mediating	O
repression	O
by	O
the	O
upstream	B-DNA
regulatory	I-DNA
region	I-DNA
.	O

We	O
have	O
isolated	O
the	O
5	B-DNA
'	I-DNA
region	I-DNA
of	O
the	O
ecto-5'-nucleotidase	B-DNA
(	I-DNA
low	I-DNA
K	I-DNA
(	I-DNA
m	I-DNA
)	I-DNA
5'-NT	I-DNA
)	I-DNA
gene	I-DNA
and	O
established	O
that	O
a	O
969-base	B-DNA
pair	I-DNA
(	I-DNA
bp	I-DNA
)	I-DNA
fragment	I-DNA
confers	O
cell-specific	O
expression	O
of	O
a	O
CAT	B-DNA
reporter	I-DNA
gene	I-DNA
that	O
correlates	O
with	O
the	O
expression	O
of	O
endogenous	B-RNA
ecto-5'-NT	I-RNA
mRNA	I-RNA
and	O
enzymatic	O
activity	O
.	O

A	O
768-bp	B-DNA
upstream	I-DNA
negative	I-DNA
regulatory	I-DNA
region	I-DNA
has	O
been	O
identified	O
that	O
conferred	O
lymphocyte-specific	O
negative	O
regulation	O
in	O
a	O
heterologous	O
system	O
with	O
a	O
244-bp	B-DNA
deoxycytidine	I-DNA
kinase	I-DNA
core	I-DNA
promoter	I-DNA
.	O

DNase	B-protein
I	I-protein
footprinting	O
identified	O
several	O
protected	O
areas	O
including	O
Sp1	B-DNA
,	I-DNA
Sp1/AP-2	I-DNA
,	I-DNA
and	I-DNA
cAMP	I-DNA
response	I-DNA
element	I-DNA
(	I-DNA
CRE	I-DNA
)	I-DNA
binding	I-DNA
sites	I-DNA
within	O
the	O
201-bp	O
core	O
promoter	O
region	O
and	O
Sp1	B-DNA
,	I-DNA
NRE-2a	I-DNA
,	I-DNA
TCF-1/LEF-1	I-DNA
,	I-DNA
and	I-DNA
Sp1/NF-AT	I-DNA
binding	I-DNA
sites	I-DNA
in	O
the	O
upstream	B-DNA
regulatory	I-DNA
region	I-DNA
.	O

Whereas	O
the	O
CRE	B-DNA
site	I-DNA
was	O
essential	O
in	O
mediating	O
the	O
negative	O
activity	O
of	O
the	O
upstream	B-DNA
regulatory	I-DNA
region	I-DNA
in	O
Jurkat	B-cell_line
but	O
not	O
in	O
HeLa	B-cell_line
cells	I-cell_line
,	O
mutation	O
of	O
the	O
Sp1/AP-2	B-DNA
site	I-DNA
decreased	O
promoter	O
activity	O
in	O
both	O
cell	O
lines	O
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
analysis	O
of	O
proteins	O
binding	O
to	O
the	O
CRE	B-DNA
site	I-DNA
identified	O
both	O
ATF-1	B-protein
and	O
ATF-2	B-protein
in	O
Jurkat	B-cell_line
cells	I-cell_line
.	O

Finally	O
,	O
phorbol	O
12-myristate	O
13-acetate	O
increased	O
the	O
activity	O
of	O
both	O
the	O
core	O
and	O
the	O
969-bp	B-DNA
promoter	I-DNA
fragments	I-DNA
,	O
and	O
this	O
increase	O
was	O
abrogated	O
by	O
mutations	O
at	O
the	O
CRE	B-DNA
site	I-DNA
.	O

In	O
summary	O
,	O
we	O
have	O
identified	O
a	O
tissue-specific	B-DNA
regulatory	I-DNA
region	I-DNA
5	O
'	O
of	O
the	O
ecto-5'-NT	B-DNA
core	I-DNA
promoter	I-DNA
that	O
requires	O
the	O
presence	O
of	O
a	O
functional	O
CRE	B-DNA
site	I-DNA
within	O
the	O
basal	B-DNA
promoter	I-DNA
for	O
its	O
suppressive	O
activity	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Â©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

274	NULL
,	NULL
No	NULL
.	NULL

32	NULL
,	NULL
Issue	NULL
of	NULL
August	NULL
6	NULL
,	NULL
pp	NULL
.	NULL

22705-22712	NULL
,	NULL
1999	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Tissue-specific	NULL
Regulation	NULL
of	NULL
the	NULL
Ecto-5'-nucleotidase	NULL
Promoter	NULL
ROLE	NULL
OF	NULL
THE	NULL
cAMP	NULL
RESPONSE	NULL
ELEMENT	NULL
SITE	NULL
IN	NULL
MEDIATING	NULL
REPRESSION	NULL
BY	NULL
THE	NULL
UPSTREAM	NULL
REGULATORY	NULL
REGION*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
11	NULL
,	NULL
1999	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
May	NULL
13	NULL
,	NULL
1999	NULL
)	NULL
Jozef	NULL
Spychala	NULL
#	NULL
,	NULL
Albert	NULL
G.	NULL
Zimmermann	NULL
,	NULL
and	NULL
Beverly	NULL
S.	NULL
Mitchell	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
Pharmacology	NULL
and	NULL
Internal	NULL
Medicine	NULL
,	NULL
Lineberger	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
North	NULL
Carolina	NULL
27599-6573	NULL
We	NULL
have	NULL
isolated	NULL
the	NULL
5	NULL
region	NULL
of	NULL
the	NULL
ecto-5'-nucleotidase	NULL
(	NULL
low	NULL
K	NULL
,	NULL
,	NULL
,	NULL
5'-NT	NULL
)	NULL
gene	NULL
and	NULL
established	NULL
that	NULL
a	NULL
969-base	NULL
pair	NULL
(	NULL
bp	NULL
)	NULL
fragment	NULL
confers	NULL
cell-specific	NULL
expression	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
that	NULL
correlates	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
endogenous	NULL
ecto-5'-NT	NULL
mRNA	NULL
and	NULL
enzymatic	NULL
activity	NULL
.	NULL

A	NULL
768-bp	NULL
upstream	NULL
negative	NULL
regulatory	NULL
region	NULL
has	NULL
been	NULL
identified	NULL
that	NULL
conferred	NULL
lymphocyte-specific	NULL
negative	NULL
regulation	NULL
in	NULL
a	NULL
heterologous	NULL
system	NULL
with	NULL
a	NULL
244-bp	NULL
de-oxycytidine	NULL
kinase	NULL
core	NULL
promoter	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
identified	NULL
several	NULL
protected	NULL
areas	NULL
including	NULL
Spl	NULL
,	NULL
Spl	NULL
AP-2	NULL
,	NULL
and	NULL
cAMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
201-bp	NULL
core	NULL
promoter	NULL
region	NULL
and	NULL
Spl	NULL
,	NULL
NRE-2a	NULL
,	NULL
TCF-ULEF-1	NULL
,	NULL
and	NULL
Spl/NF-AT	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
.	NULL

Whereas	NULL
the	NULL
CRE	NULL
site	NULL
was	NULL
essential	NULL
in	NULL
mediating	NULL
the	NULL
negative	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
in	NULL
Jurkat	NULL
but	NULL
not	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
SpU/AP-2	NULL
site	NULL
decreased	NULL
promoter	NULL
activity	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
analysis	NULL
of	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
CRE	NULL
site	NULL
identified	NULL
both	NULL
ATF-1	NULL
and	NULL
ATF-2	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
increased	NULL
the	NULL
activity	NULL
of	NULL
both	NULL
the	NULL
core	NULL
and	NULL
the	NULL
969-bp	NULL
promoter	NULL
fragments	NULL
,	NULL
and	NULL
this	NULL
increase	NULL
was	NULL
abrogated	NULL
by	NULL
mutations	NULL
at	NULL
the	NULL
CRE	NULL
site	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
tissue-specific	NULL
regulatory	NULL
region	NULL
5	NULL
of	NULL
the	NULL
ecto-5'-NT	NULL
core	NULL
promoter	NULL
that	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
functional	NULL
CRE	NULL
site	NULL
within	NULL
the	NULL
basal	NULL
promoter	NULL
for	NULL
its	NULL
suppressive	NULL
activity	NULL
.	NULL

Ecto-5'-nucleotidase	NULL
(	NULL
low	NULL
K	NULL
,	NULL
,	NULL
5'-NT	NULL
,	NULL
``	NULL
ecto-5'-NT	NULL
,	NULL
EC	NULL
8.1.8.5	NULL
)	NULL
is	NULL
an	NULL
extracellular	NULL
enzyme	NULL
that	NULL
is	NULL
anchored	NULL
to	NULL
the	NULL
cell	NULL
membrane	NULL
through	NULL
a	NULL
glycosyl	NULL
phosphatidylinositol	NULL
linkage	NULL
.	NULL

The	NULL
enzyme	NULL
dephosphorylates	NULL
purine	NULL
and	NULL
pyrimidine	NULL
nucleoside	NULL
monophosphates	NULL
to	NULL
the	NULL
corresponding	NULL
nucleosides	NULL
and	NULL
generates	NULL
adenosine	NULL
from	NULL
extracellular	NULL
AMP	NULL
.	NULL

Adenosine	NULL
may	NULL
then	NULL
interact	NULL
with	NULL
a	NULL
family	NULL
of	NULL
cognate	NULL
receptors	NULL
to	NULL
produce	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
physiological	NULL
effects	NULL
that	NULL
include	NULL
the	NULL
regulation	NULL
of	NULL
cardiovascular	NULL
and	NULL
cerebral	NULL
blood	NULL
flow	NULL
(	NULL
1	NULL
)	NULL
,	NULL
cytoprotection	NULL
in	NULL
myocardial	NULL
and	NULL
cerebrovascular	NULL
ischemia	NULL
(	NULL
2	NULL
)	NULL
,	NULL
and	NULL
inhibition	NULL
of	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
RO1-CA84085	NULL
(	NULL
to	NULL
B.	NULL
S.	NULL
M.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

J	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Pharmacol-ogy	NULL
,	NULL
1106	NULL
Mary	NULL
Ellen	NULL
Jones	NULL
Bldg	NULL
.	NULL

,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
NC	NULL
27599-7865	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
919-966-4340	NULL
;	NULL
Fax	NULL
:	NULL
919-966-5640	NULL
;	NULL
E-mail	NULL
:	NULL
jozek	NULL
@	NULL
med.unc.edu	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
NT	NULL
,	NULL
nucleotidase	NULL
;	NULL
MOPS	NULL
,	NULL
4-morpho-linepropanesulfonic	NULL
acid	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyl-transferase	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
;	NULL
CRE	NULL
,	NULL
cAMP	NULL
response	NULL
element	NULL
;	NULL
CREB	NULL
,	NULL
CRE-binding	NULL
protein	NULL
;	NULL
CREM	NULL
,	NULL
CRE	NULL
modulator	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
dCK	NULL
,	NULL
deoxyeyti-dine	NULL
kinase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
many	NULL
aspects	NULL
of	NULL
immune	NULL
function	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

Adenosine	NULL
,	NULL
which	NULL
may	NULL
accumulate	NULL
to	NULL
high	NULL
concentrations	NULL
in	NULL
solid	NULL
tumors	NULL
,	NULL
has	NULL
also	NULL
been	NULL
postulated	NULL
to	NULL
be	NULL
an	NULL
important	NULL
factor	NULL
in	NULL
stimulating	NULL
an-giogenesis	NULL
(	NULL
7	NULL
)	NULL
,	NULL
cancer	NULL
growth	NULL
through	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
A	NULL
,	NULL
adenosine	NULL
receptors	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
in	NULL
inhibiting	NULL
the	NULL
immune	NULL
response	NULL
toward	NULL
the	NULL
malignant	NULL
tissue	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
investigating	NULL
the	NULL
regulation	NULL
of	NULL
adenosine-metabolizing	NULL
enzymes	NULL
may	NULL
have	NULL
important	NULL
impact	NULL
on	NULL
the	NULL
understanding	NULL
of	NULL
tumor	NULL
biology	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
ecto-5'-nucleotidase	NULL
,	NULL
although	NULL
variable	NULL
,	NULL
is	NULL
frequently	NULL
decreased	NULL
as	NULL
a	NULL
result	NULL
of	NULL
neoplastic	NULL
transformation	NULL
of	NULL
cells	NULL
of	NULL
hematopoietic	NULL
origin	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
elevated	NULL
activity	NULL
of	NULL
ecto-5'-NT	NULL
has	NULL
been	NULL
found	NULL
in	NULL
breast	NULL
carcinoma	NULL
(	NULL
11	NULL
)	NULL
,	NULL
gastric	NULL
cancer	NULL
(	NULL
12	NULL
)	NULL
,	NULL
pancreatic	NULL
cancer	NULL
(	NULL
13	NULL
)	NULL
,	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
(	NULL
10	NULL
,	NULL
14	NULL
)	NULL
,	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
Walker	NULL
256	NULL
carcinoma	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Human	NULL
renal	NULL
carcinoma	NULL
cell	NULL
lines	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
butyric	NULL
acid	NULL
have	NULL
demonstrated	NULL
both	NULL
an	NULL
increase	NULL
(	NULL
Cur	NULL
cell	NULL
line	NULL
)	NULL
and	NULL
a	NULL
decrease	NULL
(	NULL
Caki	NULL
cell	NULL
line	NULL
)	NULL
in	NULL
ecto-5'-NT	NULL
activity	NULL
(	NULL
17	NULL
)	NULL
,	NULL
demonstrating	NULL
a	NULL
complex	NULL
,	NULL
and	NULL
perhaps	NULL
context-dependent	NULL
,	NULL
pattern	NULL
of	NULL
ecto-5'-NT	NULL
expression	NULL
in	NULL
differentiation	NULL
and	NULL
malignant	NULL
transformation	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
ecto-5'-NT	NULL
in	NULL
thymocytes	NULL
,	NULL
lymphocytes	NULL
,	NULL
granulocytes	NULL
,	NULL
and	NULL
undifferentiated	NULL
myeloid	NULL
cells	NULL
is	NULL
very	NULL
low	NULL
.	NULL

However	NULL
,	NULL
differentiation	NULL
of	NULL
myeloid	NULL
precursors	NULL
along	NULL
the	NULL
mono-cytic	NULL
lineage	NULL
into	NULL
macrophages	NULL
results	NULL
in	NULL
a	NULL
sharp	NULL
increase	NULL
in	NULL
activity	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

The	NULL
enzyme	NULL
activity	NULL
is	NULL
lower	NULL
than	NULL
normal	NULL
or	NULL
undetectable	NULL
in	NULL
lymphocytes	NULL
from	NULL
patients	NULL
with	NULL
chronic	NULL
lym-phocytic	NULL
leukemia	NULL
and	NULL
infectious	NULL
mononucleosis	NULL
(	NULL
21	NULL
)	NULL
and	NULL
in	NULL
CD8*	NULL
lymphocytes	NULL
from	NULL
AIDS	NULL
patients	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
strong	NULL
immunosuppressive	NULL
activity	NULL
of	NULL
adenosine	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
the	NULL
variability	NULL
in	NULL
expression	NULL
of	NULL
this	NULL
enzymatic	NULL
activity	NULL
among	NULL
lymphoid	NULL
cell	NULL
populations	NULL
has	NULL
functional	NULL
significance	NULL
.	NULL

In	NULL
order	NULL
to	NULL
characterize	NULL
the	NULL
regulatory	NULL
elements	NULL
that	NULL
contribute	NULL
to	NULL
the	NULL
transcriptional	NULL
regulation	NULL
and	NULL
tissue-specific	NULL
expression	NULL
of	NULL
ecto-5'-NT	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
core	NULL
promoter	NULL
and	NULL
upstream	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-Fetal	NULL
calf	NULL
serum	NULL
was	NULL
obtained	NULL
from	NULL
HiClone	NULL
and	NULL
Sigma	NULL
.	NULL

TRI	NULL
Reagent	NULL
,	NULL
a	NULL
high	NULL
efficiency	NULL
hybridization	NULL
system	NULL
,	NULL
and	NULL
Northern/	NULL
Southern	NULL
transfer	NULL
solution	NULL
were	NULL
obtained	NULL
from	NULL
Molecular	NULL
Research	NULL
Center	NULL
Inc.	NULL
(	NULL
Cincinnati	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

Restriction	NULL
enzymes	NULL
,	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
,	NULL
Taq	NULL
polymerase	NULL
,	NULL
and	NULL
polynucleotide	NULL
kinase	NULL
were	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Reverse	NULL
transcriptase	NULL
was	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
D-threo	NULL
[	NULL
dichloroacetyl-1-'*CJchloramphenicol	NULL
(	NULL
56	NULL
mCi/mmol	NULL
)	NULL
was	NULL
from	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
.	NULL

Cells-The	NULL
T-lymphoblast	NULL
cell	NULL
line	NULL
K-T1	NULL
(	NULL
28	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Dr.	NULL
D.	NULL
Sorscher	NULL
(	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
)	NULL
.	NULL

The	NULL
K562	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
(	NULL
ATCC	NULL
CCL-2438	NULL
)	NULL
,	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
(	NULL
T-ALL	NULL
origin	NULL
)	NULL
,	NULL
U987	NULL
cell	NULL
line	NULL
,	NULL
PC-12	NULL
pheochromocytoma	NULL
,	NULL
Helia	NULL
S8	NULL
cervical	NULL
carcinoma	NULL
,	NULL
and	NULL
WI-88	NULL
fibroblasts	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
ATCC	NULL
(	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

Jurkat	NULL
,	NULL
K-T1	NULL
,	NULL
K562	NULL
,	NULL
and	NULL
U987	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

WI-88	NULL
,	NULL
PC-12	NULL
,	NULL
and	NULL
Hela	NULL
S3	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
Eagle	NULL
's	NULL
minimal	NULL
essential	NULL
medium	NULL
sup	NULL
22705	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
22706	NULL
plemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
nonessential	NULL
amino	NULL
acids	NULL
,	NULL
sodium	NULL
pyruvate	NULL
,	NULL
penicillin	NULL
,	NULL
and	NULL
streptomycin	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
purified	NULL
by	NULL
the	NULL
acid	NULL
guanidinium	NULL
thiocyanate/phenol/chloroform	NULL
method	NULL
(	NULL
24	NULL
)	NULL
was	NULL
elec-trophoresed	NULL
in	NULL
1	NULL
%	NULL
agarose	NULL
with	NULL
50	NULL
mM	NULL
MOPS	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
and	NULL
1	NULL
M	NULL
formaldehyde	NULL
buffer	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
Nytran	NULL
nylon	NULL
membranes	NULL
overnight	NULL
,	NULL
fixed	NULL
in	NULL
a	NULL
vacuum	NULL
oven	NULL
at	NULL
80	NULL
Â°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
a	NULL
randomly	NULL
primed	NULL
1660-bp	NULL
Aval/HindIII	NULL
cDNA	NULL
fragment	NULL
extending	NULL
from	NULL
bp	NULL
8	NULL
to	NULL
1668	NULL
of	NULL
the	NULL
ecto-5'-NT	NULL
coding	NULL
region	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
in	NULL
high	NULL
efficiency	NULL
hybridization	NULL
solution	NULL
with	NULL
50	NULL
%	NULL
form-amide	NULL
,	NULL
with	NULL
a	NULL
nylon	NULL
membrane	NULL
sandwiched	NULL
between	NULL
two	NULL
Whatman	NULL
3MM	NULL
papers	NULL
,	NULL
in	NULL
a	NULL
rotating	NULL
incubator	NULL
at	NULL
42Â°C	NULL
for	NULL
24	NULL
h.	NULL
Blots	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
1	NULL
%	NULL
SSC	NULL
,	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
once	NULL
at	NULL
60	NULL
Â°C	NULL
and	NULL
exposed	NULL
overnight	NULL
at	NULL
-80	NULL
Â°C	NULL
.	NULL

Plasmid	NULL
/Promoter	NULL
Constructs-The	NULL
chloramphenicol	NULL
acetyltrans-ferase	NULL
(	NULL
CAT	NULL
)	NULL
vector	NULL
pCAT-Basic	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
was	NULL
used	NULL
in	NULL
reporter	NULL
gene	NULL
assays	NULL
to	NULL
examine	NULL
ecto-5'-NT	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
corresponding	NULL
promoter	NULL
fragments	NULL
were	NULL
generated	NULL
by	NULL
restriction	NULL
digests	NULL
or	NULL
by	NULL
PCR	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
using	NULL
Pfu	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
followed	NULL
by	NULL
five	NULL
cycles	NULL
with	NULL
Taq	NULL
polymerase	NULL
(	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
pCR	NULL
2.1	NULL
vector	NULL
(	NULL
Invitrogen	NULL
,	NULL
Carlsbad	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
sequenced	NULL
.	NULL

The	NULL
heterologous	NULL
ecto-5'-NT/deoxycytidine	NULL
kinase	NULL
(	NULL
dCK	NULL
)	NULL
promoter	NULL
construct	NULL
was	NULL
produced	NULL
by	NULL
replacing	NULL
a	NULL
fragment	NULL
encompassing	NULL
the	NULL
5'-NT	NULL
proximal	NULL
promoter	NULL
fragment	NULL
and	NULL
part	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
from	NULL
pCAT-Basic	NULL
with	NULL
the	NULL
corresponding	NULL
dCK-244	NULL
Pstfl/Ndel	NULL
fragment	NULL
containing	NULL
the	NULL
244-bp	NULL
dCK	NULL
promoter	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Plasmid	NULL
DNA	NULL
used	NULL
for	NULL
transfections	NULL
was	NULL
purified	NULL
using	NULL
Quiagen	NULL
Maxi	NULL
columns	NULL
,	NULL
and	NULL
isopro-pyl	NULL
alcohol-precipitated	NULL
plasmid	NULL
DNA	NULL
preparations	NULL
were	NULL
further	NULL
depro-teinated	NULL
by	NULL
the	NULL
sequential	NULL
treatment	NULL
with	NULL
equal	NULL
volumes	NULL
of	NULL
phenol/	NULL
chloroform/isoamyl	NULL
alcohol	NULL
(	NULL
50:49:1	NULL
)	NULL
and	NULL
twice	NULL
with	NULL
chloroform	NULL
.	NULL

Final	NULL
plasmid	NULL
DNA	NULL
preparations	NULL
were	NULL
precipitated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.1	NULL
M	NULL
sodium	NULL
acetate	NULL
with	NULL
70	NULL
%	NULL
ethanol	NULL
,	NULL
washed	NULL
with	NULL
75	NULL
%	NULL
ethanol	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
H	NULL
,	NULL
O	NULL
at	NULL
2	NULL
mg/ml	NULL
.	NULL

The	NULL
quality	NULL
of	NULL
DNA	NULL
was	NULL
tested	NULL
on	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
with	NULL
and	NULL
without	NULL
treatment	NULL
by	NULL
HindIII	NULL
and	NULL
Xbal	NULL
.	NULL

Cell	NULL
Transfections-Cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Gene-Pulser	NULL
.	NULL

Approximately	NULL
6.0	NULL
x	NULL
10Â°	NULL
Jurkat	NULL
,	NULL
K-T1	NULL
,	NULL
K562	NULL
,	NULL
or	NULL
U937	NULL
cells	NULL
;	NULL
8.0	NULL
X	NULL
10Â°	NULL
Hela	NULL
cells	NULL
;	NULL
and	NULL
1.0	NULL
X	NULL
10Â°	NULL
fibroblasts	NULL
were	NULL
transfected	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
equimolar	NULL
amounts	NULL
of	NULL
the	NULL
promoter	NULL
constructs	NULL
corresponding	NULL
to	NULL
20	NULL
ug	NULL
of	NULL
control	NULL
pCAT-Basic	NULL
plasmid	NULL
.	NULL

Herring	NULL
sperm	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
a	NULL
total	NULL
quantity	NULL
of	NULL
50	NULL
ug	NULL
of	NULL
DNA/electroporation	NULL
.	NULL

Electroporation	NULL
efficiency	NULL
was	NULL
determined	NULL
by	NULL
transfecting	NULL
separate	NULL
aliquots	NULL
of	NULL
cells	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
B-galactosidase	NULL
plasmids	NULL
driven	NULL
by	NULL
B-actin	NULL
promoter	NULL
and	NULL
30	NULL
pug	NULL
of	NULL
herring	NULL
sperm	NULL
DNA	NULL
.	NULL

When	NULL
the	NULL
effect	NULL
of	NULL
PMA	NULL
was	NULL
tested	NULL
on	NULL
ecto-5'-NT	NULL
promoter	NULL
activity	NULL
,	NULL
co-transfection	NULL
of	NULL
B-galactosidase	NULL
and	NULL
CAT	NULL
constructs	NULL
was	NULL
performed	NULL
to	NULL
account	NULL
for	NULL
variable	NULL
cell	NULL
growth	NULL
rates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
.	NULL

Electroporations	NULL
were	NULL
performed	NULL
at	NULL
300	NULL
V	NULL
and	NULL
960	NULL
microfarads	NULL
(	NULL
330	NULL
V	NULL
and	NULL
960	NULL
microfarads	NULL
for	NULL
Hela	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
subsequently	NULL
suspended	NULL
in	NULL
12	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
20	NULL
%	NULL
horse	NULL
serum	NULL
.	NULL

After	NULL
44-48	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
and	NULL
freeze-thawed	NULL
three	NULL
times	NULL
with	NULL
80	NULL
ul	NULL
of	NULL
0.25	NULL
M	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
containing	NULL
0.1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
and	NULL
10	NULL
ug/ml	NULL
pepstatin	NULL
and	NULL
leupeptin	NULL
.	NULL

CAT	NULL
activity	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
supernatants	NULL
following	NULL
treatment	NULL
of	NULL
extracts	NULL
at	NULL
62	NULL
Â°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

CAT	NULL
and	NULL
B-Galactosidase	NULL
Assays-Chloramphenicol	NULL
acetyltrans-ferase	NULL
activity	NULL
was	NULL
measured	NULL
at	NULL
37	NULL
Â°C	NULL
in	NULL
a	NULL
reaction	NULL
medium	NULL
containing	NULL
1	NULL
mM	NULL
dibutyryl	NULL
CoA	NULL
(	NULL
25	NULL
ug/assay	NULL
)	NULL
,	NULL
10	NULL
uM	NULL
D-threo	NULL
[	NULL
dichloroacetyl-1-	NULL
(	NULL
56	NULL
mCi/mmol	NULL
,	NULL
0.25	NULL
uCi/assay	NULL
)	NULL
in	NULL
0.25	NULL
M	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
buffer	NULL
.	NULL

The	NULL
incubation	NULL
was	NULL
initiated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
2-50	NULL
ul	NULL
of	NULL
cell	NULL
extract	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
125	NULL
pl	NULL
and	NULL
terminated	NULL
after	NULL
1-6	NULL
h	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
300	NULL
ul	NULL
of	NULL
xylenes	NULL
.	NULL

Following	NULL
three	NULL
extractions	NULL
,	NULL
reaction	NULL
products	NULL
in	NULL
the	NULL
organic	NULL
phase	NULL
were	NULL
counted	NULL
in	NULL
a	NULL
scintillation	NULL
counter	NULL
.	NULL

Reaction	NULL
velocity	NULL
was	NULL
expressed	NULL
as	NULL
cpm	NULL
converted/h/mg	NULL
of	NULL
protein	NULL
.	NULL

Reaction	NULL
time	NULL
and	NULL
extract	NULL
amount	NULL
were	NULL
adjusted	NULL
so	NULL
that	NULL
no	NULL
more	NULL
than	NULL
30	NULL
%	NULL
of	NULL
substrate	NULL
was	NULL
utilized	NULL
.	NULL

The	NULL
final	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
-fold	NULL
increase	NULL
or	NULL
decrease	NULL
over	NULL
values	NULL
obtained	NULL
with	NULL
the	NULL
pCAT	NULL
Basic	NULL
Ecto-5'-NT	NULL
Promoter	NULL
Regulation	NULL
vector	NULL
alone	NULL
.	NULL

To	NULL
normalize	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
the	NULL
CAT	NULL
activity	NULL
was	NULL
divided	NULL
by	NULL
the	NULL
B-galactosidase	NULL
activity	NULL
of	NULL
simultaneous	NULL
transfec-tions	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
was	NULL
assayed	NULL
spectrophotometrically	NULL
at	NULL
564	NULL
nm	NULL
in	NULL
25	NULL
mM	NULL
phosphate	NULL
buffer	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
3	NULL
mg/ml	NULL
chlorophenol	NULL
red-6-D-galactopyranoside	NULL
at	NULL
37	NULL
Â°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
initiated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
5-25	NULL
ul	NULL
of	NULL
cell	NULL
extract	NULL
and	NULL
analyzed	NULL
for	NULL
1	NULL
min	NULL
.	NULL

The	NULL
linear	NULL
portion	NULL
of	NULL
the	NULL
curve	NULL
was	NULL
used	NULL
to	NULL
compute	NULL
0	NULL
order	NULL
reaction	NULL
rate	NULL
and	NULL
expressed	NULL
as	NULL
pmol	NULL
of	NULL
substrate	NULL
used/min/mg	NULL
of	NULL
protein	NULL
.	NULL

The	NULL
-galactosidase	NULL
activity	NULL
varied	NULL
by	NULL
less	NULL
than	NULL
20	NULL
%	NULL
in	NULL
duplicate	NULL
cell	NULL
sam-ples	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
assayed	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts-Extracts	NULL
were	NULL
made	NULL
from	NULL
logarith-mically	NULL
growing	NULL
Jurkat	NULL
T	NULL
cells	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
with	NULL
modifications	NULL
as	NULL
described	NULL
by	NULL
Blake	NULL
et	NULL
al	NULL
.	NULL

(	NULL
80	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
homogenized	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.75	NULL
mM	NULL
spermidine	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
mm	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
phenyimethylsulfonyl	NULL
fluoride	NULL
,	NULL
100	NULL
nM	NULL
ocadaic	NULL
acid	NULL
)	NULL
,	NULL
and	NULL
the	NULL
nuclei	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
at	NULL
30,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
s.	NULL
Nuclear	NULL
factors	NULL
were	NULL
extracted	NULL
in	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
mm	NULL
EGTA	NULL
,	NULL
2	NULL
my	NULL
DTT	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
,	NULL
0.75	NULL
mM	NULL
spermidine	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
100	NULL
nM	NULL
ocadaic	NULL
acid	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
centrifugation	NULL
at	NULL
80,000	NULL
X	NULL
g	NULL
for	NULL
45	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
dialyzed	NULL
in	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
100	NULL
mM	NULL
KCl	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
12.5	NULL
mM	NULL
MgCl	NULL
,	NULL
)	NULL
,	NULL
aliquoted	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-70	NULL
Â°C	NULL
(	NULL
81	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
Footprinting-T'wo	NULL
DNA	NULL
probes	NULL
encompassing	NULL
the	NULL
878-bp	NULL
fragment	NULL
(	NULL
from	NULL
-48	NULL
to	NULL
-426	NULL
from	NULL
the	NULL
ATG	NULL
site	NULL
,	NULL
cluster	NULL
I	NULL
and	NULL
II	NULL
,	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
and	NULL
406-bp	NULL
fragment	NULL
(	NULL
from	NULL
-425	NULL
to	NULL
-882	NULL
,	NULL
cluster	NULL
III	NULL
)	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
with	NULL
Pfu	NULL
DNA	NULL
polymerase	NULL
.	NULL

Resulting	NULL
fragments	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
Taq	NULL
polymerase	NULL
,	NULL
subcloned	NULL
into	NULL
the	NULL
pCR	NULL
2.1	NULL
vector	NULL
,	NULL
and	NULL
digested	NULL
with	NULL
the	NULL
appropriate	NULL
restriction	NULL
enzymes	NULL
to	NULL
create	NULL
a	NULL
5'-overhang	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
at	NULL
the	NULL
3'-end	NULL
.	NULL

The	NULL
3'-	NULL
ends	NULL
of	NULL
the	NULL
coding	NULL
strands	NULL
were	NULL
filled	NULL
in	NULL
with	NULL
radiolabeled	NULL
dCTP	NULL
using	NULL
DNA	NULL
polymerase	NULL
large	NULL
Klenow	NULL
fragment	NULL
.	NULL

The	NULL
resulting	NULL
probes	NULL
were	NULL
digested	NULL
at	NULL
the	NULL
opposite	NULL
end	NULL
to	NULL
ensure	NULL
one-strand	NULL
labeling	NULL
,	NULL
gel-purified	NULL
on	NULL
a	NULL
6	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
eluted	NULL
by	NULL
the	NULL
``	NULL
crush	NULL
and	NULL
soak	NULL
``	NULL
method	NULL
(	NULL
29	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
Blake	NULL
et	NULL
al	NULL
.	NULL

(	NULL
30	NULL
)	NULL
.	NULL

Ten	NULL
ng	NULL
of	NULL
Â°Â°P-labeled	NULL
DNA	NULL
were	NULL
incubated	NULL
with	NULL
120	NULL
and	NULL
240	NULL
ug	NULL
of	NULL
Jurkat	NULL
and	NULL
Hela	NULL
cell	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
15	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
6.1	NULL
%	NULL
glycerol	NULL
,	NULL
0.07	NULL
mM	NULL
EDTA	NULL
,	NULL
0.07	NULL
mM	NULL
EGTA	NULL
,	NULL
7.2	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
89	NULL
mM	NULL
KCl	NULL
,	NULL
7.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
0.7	NULL
mM	NULL
DTT	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
,	NULL
after	NULL
which	NULL
CaCl	NULL
,	NULL
(	NULL
2	NULL
mM	NULL
final	NULL
concentration	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
probe	NULL
was	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
(	NULL
Worthington	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
3	NULL
min	NULL
.	NULL

Digestions	NULL
were	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
2	NULL
volumes	NULL
of	NULL
100	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
20	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
pg/ml	NULL
proteinase	NULL
K	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
glycogen	NULL
.	NULL

After	NULL
an	NULL
incubation	NULL
at	NULL
37	NULL
Â°C	NULL
for	NULL
20	NULL
min	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
extracted	NULL
with	NULL
phenol/	NULL
chloroform	NULL
,	NULL
precipitated	NULL
with	NULL
ethanol	NULL
,	NULL
resuspended	NULL
in	NULL
formamide	NULL
loading	NULL
dye	NULL
,	NULL
and	NULL
analyzed	NULL
on	NULL
an	NULL
8	NULL
M	NULL
urea	NULL
,	NULL
6	NULL
%	NULL
polyacrylamide	NULL
sequencing	NULL
gel	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-Wild-type	NULL
and	NULL
mutant	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
generated	NULL
by	NULL
annealing	NULL
complementary	NULL
single-stranded	NULL
oligonucleotides	NULL
yielding	NULL
5'-overhangs	NULL
;	NULL
100	NULL
ng	NULL
was	NULL
labeled	NULL
by	NULL
fill-in	NULL
using	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
.	NULL

Labeled	NULL
probes	NULL
were	NULL
purified	NULL
on	NULL
1	NULL
ml	NULL
of	NULL
Sephadex-G50	NULL
(	NULL
Sigma	NULL
)	NULL
col-umns	NULL
.	NULL

The	NULL
flow-through	NULL
was	NULL
precipitated	NULL
with	NULL
o	NULL
volume	NULL
of	NULL
3	NULL
M	NULL
sodium	NULL
acetate	NULL
and	NULL
2.5	NULL
volumes	NULL
of	NULL
ethanol	NULL
,	NULL
washed	NULL
with	NULL
75	NULL
%	NULL
ethanol	NULL
,	NULL
and	NULL
resuspended	NULL
at	NULL
20,000	NULL
cpm/ul	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
unlabeled	NULL
wild-type	NULL
and	NULL
mutant	NULL
oligonucleotides	NULL
were	NULL
prepared	NULL
by	NULL
using	NULL
unlabeled	NULL
deoxynucleotides	NULL
for	NULL
fill-in	NULL
and	NULL
precipitated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

One	NULL
pl	NULL
of	NULL
probe	NULL
(	NULL
approximately	NULL
0.1	NULL
ng	NULL
of	NULL
DNA	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
8	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
preincubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
competitor	NULL
or	NULL
for	NULL
30-60	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibod-ies	NULL
.	NULL

Probe	NULL
was	NULL
added	NULL
to	NULL
the	NULL
mixture	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
re	NULL
TaBLE	NULL
I	NULL
Sequences	NULL
of	NULL
mutated	NULL
CRE	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
Sp1/AP-2	NULL
sites	NULL
and	NULL
of	NULL
oligonucleotides	NULL
used	NULL
in	NULL
EMSA	NULL
Site	NULL
Wild	NULL
type	NULL
MutatedÂ®	NULL
For	NULL
EMSA	NULL
(	NULL
wild	NULL
type	NULL
)	NULL
CRE	NULL
TGACGTCG	NULL
TGAACTCG	NULL
GGTCGGATCGGGTGACGTCGCGAACTTGCGCCTGG	NULL
SpUAP-2	NULL
cecececcesc	NULL
CCcaaccttce	NULL
Spl	NULL
cececece	NULL
CAACCAAC	NULL
TCF/LEF	NULL
TCTTTGAA	NULL
TATTCCAA	NULL
*	NULL
Mutated	NULL
nucleotides	NULL
are	NULL
underlined	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Ecto-5'-NT	NULL
Promoter	NULL
Regulation	NULL
solved	NULL
on	NULL
native	NULL
4	NULL
%	NULL
polyacrylamide	NULL
(	NULL
30:1	NULL
acrylamide/bisacrylamide	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
minigels	NULL
at	NULL
100	NULL
V	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
autoradio-graphed	NULL
.	NULL

EMSA	NULL
supershift	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
each	NULL
of	NULL
the	NULL
following	NULL
antibodies	NULL
:	NULL
ATF-1	NULL
antibody	NULL
(	NULL
sc-241X	NULL
)	NULL
,	NULL
ATF-2	NULL
(	NULL
sc-242	NULL
%	NULL
)	NULL
,	NULL
CREB-1	NULL
(	NULL
sc-186X	NULL
)	NULL
,	NULL
CREB-2	NULL
(	NULL
sc-200	NULL
)	NULL
,	NULL
CREM-1	NULL
(	NULL
sc-440X	NULL
)	NULL
,	NULL
c-Jun	NULL
(	NULL
sc-1694X	NULL
)	NULL
,	NULL
and	NULL
c-Fos	NULL
(	NULL
sc-4183	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

5'-Nucleotidase	NULL
Assay-Eeto-5'-NT	NULL
activity	NULL
in	NULL
cell	NULL
extracts	NULL
was	NULL
measured	NULL
in	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
5	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
0.1	NULL
mM	NULL
-	NULL
erythro-9	NULL
(	NULL
2-hydroxy-3-nonyl	NULL
)	NULL
adenine	NULL
(	NULL
EHNA	NULL
;	NULL
inhibitor	NULL
of	NULL
adenosine	NULL
deaminase	NULL
)	NULL
,	NULL
and	NULL
20	NULL
uM	NULL
[	NULL
8-	NULL
``	NULL
``	NULL
*CJAMP	NULL
.	NULL

Reaction	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
plastic-supported	NULL
cellulose	NULL
(	NULL
Ko-dachrome	NULL
;	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
)	NULL
in	NULL
ammonia/butanol/methanol/H,0	NULL
(	NULL
1	NULL
:	NULL
20:20:60	NULL
)	NULL
,	NULL
and	NULL
corresponding	NULL
spots	NULL
were	NULL
visualized	NULL
under	NULL
UV	NULL
light	NULL
,	NULL
excised	NULL
,	NULL
and	NULL
counted	NULL
in	NULL
a	NULL
scintillation	NULL
counter	NULL
.	NULL

RESULTS	NULL
Cell-specific	NULL
Expression	NULL
of	NULL
Ecto-5'-nucleotidase	NULL
mRNA-To	NULL
determine	NULL
the	NULL
level	NULL
of	NULL
ecto-5'-NT	NULL
mRNA	NULL
in	NULL
human	NULL
cell	NULL
lines	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

A	NULL
high	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
a	NULL
single	NULL
4.1-kilobase	NULL
mRNA	NULL
was	NULL
observed	NULL
in	NULL
cultured	NULL
human	NULL
fibroblasts	NULL
(	NULL
W138	NULL
)	NULL
,	NULL
whereas	NULL
Hela	NULL
cells	NULL
expressed	NULL
an	NULL
intermediate	NULL
level	NULL
,	NULL
and	NULL
PC-12	NULL
,	NULL
U937	NULL
,	NULL
Jurkat	NULL
,	NULL
K562	NULL
,	NULL
and	NULL
K-T1	NULL
cells	NULL
had	NULL
low	NULL
or	NULL
undetectable	NULL
levels	NULL
.	NULL

The	NULL
corresponding	NULL
ecto-5'-NT	NULL
enzyme	NULL
activities	NULL
in	NULL
cell	NULL
homogenates	NULL
were	NULL
C	NULL
g	NULL
U	NULL
I	NULL
s	NULL
1	NULL
$	NULL
Â§	NULL
$	NULL
f	NULL
Â©	NULL
I	NULL
â	NULL
m-45mg	NULL
Fag	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
ecto-5'-nucleotidase	NULL
mRNA	NULL
levels	NULL
in	NULL
human	NULL
cell	NULL
lines	NULL
.	NULL

Twenty	NULL
pg	NULL
of	NULL
total	NULL
RNA	NULL
were	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

Upper	NULL
panel	NULL
,	NULL
4.1-kb	NULL
ecto-5'-NT	NULL
mRNA	NULL
;	NULL
lower	NULL
panel	NULL
,	NULL
18	NULL
and	NULL
28	NULL
S	NULL
rRNA	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Cluster	NULL
IV	NULL
GATA	NULL
22707	NULL
319.3	NULL
+	NULL
20.6	NULL
,	NULL
29.9	NULL
+	NULL
6.1	NULL
,	NULL
6.3	NULL
+	NULL
2.4	NULL
,	NULL
2.40	NULL
+	NULL
0.62	NULL
,	NULL
0.37	NULL
+	NULL
0.17	NULL
,	NULL
0.12	NULL
+	NULL
0.14	NULL
,	NULL
and	NULL
0.40	NULL
+	NULL
0.22	NULL
nmol/min/mg	NULL
of	NULL
protein	NULL
,	NULL
respectively	NULL
(	NULL
+8.D	NULL
.	NULL

,	NULL
3-5	NULL
independent	NULL
measurements	NULL
)	NULL
.	NULL

There	NULL
was	NULL
a	NULL
863-fold	NULL
difference	NULL
in	NULL
5'-nucleotidase	NULL
activity	NULL
between	NULL
fibroblasts	NULL
and	NULL
the	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
,	NULL
and	NULL
relative	NULL
enzyme	NULL
activities	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
corresponded	NULL
with	NULL
differences	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
mRNA	NULL
expression	NULL
.	NULL

Cell-specific	NULL
Activity	NULL
of	NULL
the	NULL
Ecto-5'-nucleotidase	NULL
Promot-er-In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
ecto-5'-NT	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
several	NULL
cell	NULL
lines	NULL
with	NULL
the	NULL
pCAT-Basic	NULL
reporter	NULL
construct	NULL
containing	NULL
969	NULL
,	NULL
371	NULL
,	NULL
or	NULL
201	NULL
bp	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
full-length	NULL
969-bp	NULL
promoter	NULL
fragment	NULL
yielded	NULL
CAT	NULL
activity	NULL
that	NULL
was	NULL
consistently	NULL
lower	NULL
than	NULL
the	NULL
marginal	NULL
activity	NULL
of	NULL
the	NULL
pCAT-Basic	NULL
vector	NULL
in	NULL
Jurkat	NULL
,	NULL
K-T1	NULL
,	NULL
and	NULL
K562	NULL
cell	NULL
lines	NULL
,	NULL
whereas	NULL
relative	NULL
CAT	NULL
activity	NULL
in	NULL
U937	NULL
,	NULL
Hela	NULL
,	NULL
and	NULL
WI-38	NULL
cells	NULL
was	NULL
increased	NULL
by	NULL
10-25-fold	NULL
.	NULL

Two	NULL
further	NULL
deletions	NULL
of	NULL
5'-sequences	NULL
,	NULL
producing	NULL
371-	NULL
and	NULL
201-bp	NULL
promoter	NULL
fragments	NULL
,	NULL
caused	NULL
moderate	NULL
increases	NULL
in	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
and	NULL
K562	NULL
cells	NULL
,	NULL
no	NULL
significant	NULL
changes	NULL
in	NULL
U937	NULL
and	NULL
Hela	NULL
cells	NULL
,	NULL
and	NULL
a	NULL
significant	NULL
__	NULL
40.0	NULL
,	NULL
--	NULL
o	NULL
C	NULL
<	NULL
Â©	NULL
35.0	NULL
=	NULL
8	NULL
CiVector	NULL
@	NULL
s00	NULL
_	NULL
>	NULL
Â©201	NULL
bp	NULL
5	NULL
aso	NULL
Â©371	NULL
bp	NULL
Â®	NULL
0	NULL
Â©9569	NULL
bp	NULL
'	NULL
&	NULL
20.0	NULL
_	NULL
&	NULL
&	NULL
g	NULL
150	NULL
Â®	NULL
+	NULL
i	NULL
4	NULL
|	NULL
f	NULL
3	NULL
me	NULL
]	NULL
I|	NULL
e	NULL
@	NULL
50	NULL
|	NULL
|	NULL
|	NULL
.	NULL

i	NULL
AL_	NULL
Â¢	NULL
a.	NULL
CTL	NULL
g.4	NULL
G	NULL
h	NULL
[	NULL
mam	NULL
M	NULL
-	NULL
ct	NULL
|	NULL
Jurkat	NULL
|	NULL
-	NULL
KT4*	NULL
K562	NULL
U937	NULL
__	NULL
PCA2	NULL
``	NULL
*	NULL
_-	NULL
HeLa	NULL
wis	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Cell	NULL
specificity	NULL
of	NULL
ecto-5'-nucleotidase	NULL
promoter	NULL
fragment	NULL
activity	NULL
in	NULL
different	NULL
human	NULL
cell	NULL
lines	NULL
.	NULL

Promoter	NULL
constructs	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
3-5	NULL
independent	NULL
determinations	NULL
done	NULL
in	NULL
duplicate	NULL
.	NULL

*	NULL
,	NULL
mean	NULL
values	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

**	NULL
,	NULL
in	NULL
PC-12	NULL
cells	NULL
,	NULL
only	NULL
the	NULL
201-	NULL
and	NULL
969-bp	NULL
constructs	NULL
were	NULL
tested	NULL
.	NULL

CAAT	NULL
box	NULL
-817	NULL
-	NULL
TCCTGATAGC	NULL
TGCCGGATTT	NULL
TACCCCAATC	NULL
GTGTTTCTGC	NULL
TTCCAGGAGC	NULL
TGTCCGCGCG	NULL
AP-1	NULL
PU.1	NULL
-757	NULL
TCGCCTCTGT	NULL
TTTATCACTA	NULL
AGGTTTTAAT	NULL
TGTGAATAAA	NULL
CGAGGAACTG	NULL
GATTCGAATG	NULL
Cluster	NULL
III	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Sequence	NULL
of	NULL
the	NULL
ecto-5'-nucleotidase	NULL
promoter	NULL
with	NULL
putative	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
.	NULL

Ets-1	NULL
-639	NULL
CCAACAGGAA	NULL
GCGTCACATC	NULL
TCAGTGAGCT	NULL
TCGGCTCTCA	NULL
CAGCCCGAAA	NULL
CTGCAAGGAG	NULL
unknown	NULL
Four	NULL
clusters	NULL
of	NULL
binding	NULL
sites	NULL
were	NULL
iden-	NULL
sd	NULL
NRE-2a	NULL
W	NULL
tified	NULL
within	NULL
the	NULL
proxhnal	NULL
Qï¬gbp	NULL
ï¬gg	NULL
.	NULL

-579	NULL
CTCCTCTGCC	NULL
CÃ©eCCTCTCT	NULL
TTACTCCTCC	NULL
TCTCTGCCCC	NULL
TCAGCTCGCT	NULL
CATCTTTCTIT	NULL
ment	NULL
.	NULL

Bases	NULL
are	NULL
numbered	NULL
in	NULL
relation	NULL
to	NULL
Sp1/NF-AT	NULL
U	NULL
LEF-1/TCF-1	NULL
the	NULL
ATG	NULL
translation	NULL
start	NULL
site	NULL
in	NULL
the	NULL
first	NULL
-519	NULL
CCeeccccTe	NULL
TCrEFTCCTT	NULL
CTTTGGTTCT	NULL
TTGAAGTGAT	NULL
GAGCTAGCGC	NULL
exon	NULL
.	NULL

Consensus	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
are	NULL
in	NULL
boldface	NULL
type	NULL
and	NULL
underlined	NULL
.	NULL

Clusters	NULL
UII	NULL
and	NULL
III	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
DNase	NULL
I	NULL
protection	NULL
assay	NULL
,	NULL
and	NULL
protected	NULL
areas	NULL
are	NULL
double	NULL
underlined	NULL
.	NULL

Hypersensitive	NULL
sites	NULL
are	NULL
indicated	NULL
with	NULL
arrows	NULL
.	NULL

Cluster	NULL
II	NULL
Cluster	NULL
I	NULL
Sp-1	NULL
CAT	NULL
Box	NULL
PU.1	NULL
-397	NULL
GCGCGGGGC	NULL
@	NULL
GACCCCTCCA	NULL
ATTCCTTCCT	NULL
CGCGCCCCCG	NULL
AAAGAGCGGC	NULL
-348	NULL
4	NULL
1	NULL
U4	NULL
AP-2	NULL
-207	NULL
GGGTACCAGG	NULL
GTCGGATCGG	NULL
@	NULL
TGACG	NULL
@	NULL
TCGeC	NULL
GAACTTGCGC	NULL
CTGGCCGCCA	NULL
AGCCGGCCTC	NULL
I	NULL
UL	NULL
-	NULL
sp1	NULL
/ap-2	NULL
[	NULL
Sp1	NULL
-147	NULL
CAGGCTGAAG	NULL
AAGGACCCGC	NULL
CCC	NULL
@	NULL
@	NULL
CcTTG	NULL
ACCCococcee	NULL
CeccecTCca	NULL
GCCGscccac	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
22708	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
in	NULL
WI38	NULL
fibroblasts	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
distal	NULL
768-bp	NULL
fragment	NULL
contains	NULL
tissue-specific	NULL
regulatory	NULL
elements	NULL
that	NULL
function	NULL
to	NULL
repress	NULL
the	NULL
core	NULL
promoter	NULL
activity	NULL
in	NULL
lymphoid	NULL
(	NULL
Jurkat	NULL
and	NULL
K-T1l	NULL
)	NULL
and	NULL
erythroid	NULL
(	NULL
K562	NULL
)	NULL
cell	NULL
lines	NULL
while	NULL
enhancing	NULL
the	NULL
activity	NULL
in	NULL
WI-38	NULL
fibroblast	NULL
.	NULL

In	NULL
general	NULL
,	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
correlated	NULL
well	NULL
with	NULL
the	NULL
levels	NULL
of	NULL
mRNA	NULL
and	NULL
ecto-5'-NT	NULL
enzymatic	NULL
activity	NULL
in	NULL
a	NULL
majority	NULL
of	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
Vitro	NULL
DNase	NULL
I	NULL
Footprinting-To	NULL
identify	NULL
regulatory	NULL
elements	NULL
that	NULL
interact	NULL
with	NULL
cognate	NULL
transcription	NULL
factors	NULL
,	NULL
we	NULL
performed	NULL
in	NULL
vitro	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
using	NULL
Jurkat	NULL
T-cell	NULL
and	NULL
Hela	NULL
nuclear	NULL
extracts	NULL
.	NULL

Four	NULL
clusters	NULL
of	NULL
putative	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
were	NULL
identified	NULL
within	NULL
the	NULL
proximal	NULL
770	NULL
bp	NULL
of	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

We	NULL
have	NULL
generated	NULL
two	NULL
DNA	NULL
probes	NULL
that	NULL
encompass	NULL
cluster	NULL
I/II	NULL
and	NULL
cluster	NULL
III	NULL
and	NULL
used	NULL
them	NULL
in	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
with	NULL
Jurkat	NULL
T-cell	NULL
and	NULL
Hela	NULL
nuclear	NULL
extracts	NULL
.	NULL

Results	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
demonstrate	NULL
that	NULL
within	NULL
the	NULL
core	NULL
promoter	NULL
region	NULL
(	NULL
clus-ter	NULL
I/II	NULL
)	NULL
both	NULL
Jurkat	NULL
(	NULL
4	NULL
)	NULL
and	NULL
HeLa	NULL
(	NULL
B	NULL
)	NULL
nuclear	NULL
extracts	NULL
produce	NULL
similar	NULL
protected	NULL
areas	NULL
that	NULL
coincide	NULL
with	NULL
Spl	NULL
,	NULL
SpL/AP-2	NULL
,	NULL
and	NULL
CRE	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
.	NULL

However	NULL
,	NULL
within	NULL
cluster	NULL
III	NULL
,	NULL
a	NULL
strong	NULL
protected	NULL
area	NULL
coincident	NULL
with	NULL
a	NULL
TCF-1/LEF-1	NULL
consensus	NULL
binding	NULL
site	NULL
(	NULL
32-34	NULL
)	NULL
is	NULL
present	NULL
with	NULL
extract	NULL
from	NULL
Jurkat	NULL
cells	NULL
but	NULL
is	NULL
absent	NULL
with	NULL
Hela	NULL
nuclear	NULL
extracts	NULL
.	NULL

Further	NULL
upstream	NULL
,	NULL
an	NULL
extensive	NULL
22-bp	NULL
protected	NULL
area	NULL
that	NULL
coincides	NULL
with	NULL
adjacent	NULL
NF-AT	NULL
and	NULL
Spl	NULL
binding	NULL
sites	NULL
in	NULL
Jurkat	NULL
corresponds	NULL
to	NULL
a	NULL
more	NULL
restricted	NULL
16-bp	NULL
protected	NULL
area	NULL
representing	NULL
a	NULL
single	NULL
Spl	NULL
site	NULL
in	NULL
Helia	NULL
extracts	NULL
.	NULL

An	NULL
additional	NULL
protected	NULL
area	NULL
further	NULL
upstream	NULL
coincides	NULL
with	NULL
a	NULL
NRE-2a/2b	NULL
transcription	NULL
factor	NULL
binding	NULL
site	NULL
(	NULL
35	NULL
)	NULL
and	NULL
is	NULL
also	NULL
more	NULL
pronounced	NULL
with	NULL
the	NULL
Jurkat	NULL
T-cell	NULL
nuclear	NULL
extract	NULL
.	NULL

A	NULL
protected	NULL
area	NULL
that	NULL
does	NULL
not	NULL
correspond	NULL
to	NULL
a	NULL
known	NULL
consensus	NULL
transcription	NULL
factor	NULL
binding	NULL
site	NULL
is	NULL
present	NULL
at	NULL
bp	NULL
-579	NULL
to	NULL
-599	NULL
only	NULL
with	NULL
Jurkat	NULL
T-cell	NULL
nuclear	NULL
extract	NULL
.	NULL

Cell-specific	NULL
Activity	NULL
of	NULL
the	NULL
Upstream	NULL
Regulatory	NULL
Region	NULL
in	NULL
a	NULL
Heterologous	NULL
System-To	NULL
determine	NULL
whether	NULL
the	NULL
silencing/en-hancing	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
is	NULL
specific	NULL
for	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
or	NULL
could	NULL
be	NULL
reproduced	NULL
in	NULL
a	NULL
heterologous	NULL
system	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
chimeric	NULL
promoter	NULL
construct	NULL
containing	NULL
the	NULL
distal	NULL
768	NULL
bp	NULL
of	NULL
the	NULL
regulatory	NULL
region	NULL
ligated	NULL
to	NULL
the	NULL
244-bp	NULL
core	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
dCK	NULL
gene	NULL
(	NULL
27	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
the	NULL
upstream	NULL
promoter	NULL
fragment	NULL
decreased	NULL
CAT	NULL
expression	NULL
mediated	NULL
by	NULL
the	NULL
dCK	NULL
promoter	NULL
alone	NULL
in	NULL
Jurkat	NULL
and	NULL
K-T1	NULL
cells	NULL
by	NULL
78	NULL
%	NULL
,	NULL
whereas	NULL
it	NULL
had	NULL
a	NULL
lesser	NULL
suppressive	NULL
effect	NULL
on	NULL
dCK	NULL
promoter-mediated	NULL
CAT	NULL
expression	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
decrease	NULL
by	NULL
40	NULL
%	NULL
)	NULL
and	NULL
no	NULL
effect	NULL
in	NULL
WI88	NULL
fibroblasts	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
enhancer	NULL
activity	NULL
in	NULL
fibroblasts	NULL
,	NULL
as	NULL
seen	NULL
with	NULL
the	NULL
native	NULL
ecto-5'-NT	NULL
core	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
suggests	NULL
that	NULL
either	NULL
the	NULL
dCK	NULL
core	NULL
promoter	NULL
activity	NULL
was	NULL
already	NULL
maximal	NULL
or	NULL
that	NULL
the	NULL
function	NULL
of	NULL
the	NULL
enhancer	NULL
is	NULL
promoter-specific	NULL
.	NULL

Mutational	NULL
Analysis	NULL
of	NULL
the	NULL
Ecto-5'-NT	NULL
Core	NULL
Promoter-To	NULL
further	NULL
investigate	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
Sp1	NULL
,	NULL
AP-2	NULL
,	NULL
and	NULL
CRE	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
core	NULL
promoter	NULL
region	NULL
,	NULL
we	NULL
mutated	NULL
these	NULL
sites	NULL
as	NULL
illustrated	NULL
in	NULL
Table	NULL
I	NULL
and	NULL
tested	NULL
the	NULL
respective	NULL
mutants	NULL
individually	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

Data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
show	NULL
that	NULL
none	NULL
of	NULL
the	NULL
mutations	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
201-bp	NULL
core	NULL
promoter	NULL
region	NULL
had	NULL
any	NULL
significant	NULL
effect	NULL
in	NULL
either	NULL
Jurkat	NULL
or	NULL
Hela	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
969-bp	NULL
promoter	NULL
fragment	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
CRE	NULL
site	NULL
at	NULL
bp	NULL
184-185	NULL
produced	NULL
a	NULL
dramatic	NULL
increase	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
to	NULL
the	NULL
level	NULL
found	NULL
with	NULL
the	NULL
wild-type	NULL
201-bp	NULL
core	NULL
promoter	NULL
region	NULL
alone	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
while	NULL
resulting	NULL
in	NULL
a	NULL
50	NULL
%	NULL
decrease	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Mutations	NULL
at	NULL
the	NULL
Spl	NULL
and	NULL
especially	NULL
at	NULL
the	NULL
Spl/AP-2	NULL
site	NULL
brought	NULL
about	NULL
significant	NULL
decreases	NULL
in	NULL
promoter	NULL
activity	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
Hela	NULL
cells	NULL
.	NULL

In	NULL
Jurkat	NULL
T-cells	NULL
,	NULL
the	NULL
wild-type	NULL
969-bp	NULL
pro	NULL
Ecto-5'-NT	NULL
Promoter	NULL
Regulation	NULL
Hela	NULL
Hel	NULL
$	NULL
5o	NULL
's	NULL
$	NULL
5	NULL
oo	NULL
5	NULL
5	NULL
Â§	NULL
g	NULL
$	NULL
$	NULL
Â§	NULL
g	NULL
&	NULL
Â§	NULL
Â®	NULL
&	NULL
&	NULL
Â§	NULL
Â®	NULL
{	NULL
200	NULL
Â«	NULL
-	NULL
like-	NULL
,	NULL
d	NULL
wï¬	NULL
i	NULL
151	NULL
-a	NULL
a.	NULL
l	NULL
wee	NULL
140	NULL
=	NULL
Â®	NULL
-	NULL
=	NULL
w	NULL
CHE	NULL
=r	NULL
ilNHE2a	NULL
118	NULL
_	NULL
~~	NULL
=-	NULL
=E	NULL
als	NULL
unk	NULL
=-	NULL
fee	NULL
Â«	NULL
s	NULL
100	NULL
-k	NULL
:	NULL
p-	NULL
a	NULL
<	NULL
-	NULL
1	NULL
eu	NULL
==	NULL
95	NULL
AP2	NULL
E-	NULL
--	NULL
tuk	NULL
--	NULL
66	NULL
=	NULL
Clie	NULL
wam	NULL
Â«	NULL
<	NULL
-	NULL
#	NULL
#	NULL
as	NULL
48	NULL
u	NULL
!	NULL

-42	NULL
w	NULL
4	NULL
-	NULL
-See	NULL
&	NULL
=	NULL
Cluster	NULL
VII	NULL
Cluster	NULL
III	NULL
B	NULL
Jurkat	NULL
y	NULL
Jurkat	NULL
E	NULL
E	NULL
g	NULL
â	NULL
cg	NULL
fa	NULL
E	NULL
g	NULL
3	NULL
Â£	NULL
Â§	NULL
8	NULL
Â§	NULL
Â£	NULL
Â§	NULL
8	NULL
{	NULL
C	NULL
1a	NULL
*	NULL
200	NULL
l	NULL
f	NULL
4	NULL
$	NULL
E	NULL
CR	NULL
Unkn	NULL
.	NULL

151	NULL
at	NULL
--	NULL
``	NULL
=	NULL
140	NULL
-M	NULL
4	NULL
=/	NULL
o	NULL
==	NULL
Wit	NULL
m	NULL
CRE	NULL
l	NULL
,	NULL
si	NULL
wn	NULL
NRE	NULL
2a	NULL
1s	NULL
IFB	NULL
C	NULL
a	NULL
=	NULL
8.	NULL
cae	NULL
o	NULL
Â»	NULL
_	NULL
=z	NULL
106	NULL
2	NULL
M	NULL
_.	NULL
wa	NULL
c	NULL
Â«	NULL
ee	NULL
-	NULL
.	NULL

<	NULL
-	NULL
beE	NULL
Sp1/NFAT	NULL
82	NULL
Â«	NULL
ne	NULL
#	NULL
#	NULL
AP2	NULL
wan	NULL
#	NULL
wus	NULL
dik	NULL
=	NULL
:	NULL
~	NULL
-	NULL
``	NULL
66	NULL
mm	NULL
.	NULL

cause	NULL
dlp	NULL
<	NULL
-Se	NULL
TCF/LEF	NULL
Sp1	NULL
Te	NULL
P	NULL
fled	NULL
48	NULL
9	NULL
'	NULL
2	NULL
-	NULL
RC	NULL
40	NULL
â	NULL
a	NULL
jal	NULL
Â¥	NULL
Cluster	NULL
Ul	NULL
Cluster	NULL
III	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
assay	NULL
of	NULL
the	NULL
ecto-5'-nucleotidase	NULL
promoter	NULL
fragments	NULL
corresponding	NULL
to	NULL
clusters	NULL
I/II	NULL
and	NULL
III	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
4	NULL
)	NULL
and	NULL
from	NULL
Hela	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
were	NULL
prepared	NULL
and	NULL
processed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

DNA	NULL
markers	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

AP-2	NULL
footprint	NULL
represents	NULL
a	NULL
combined	NULL
Spl/AP-2	NULL
transcription	NULL
factor	NULL
binding	NULL
site	NULL
.	NULL

moter	NULL
activity	NULL
was	NULL
strongly	NULL
suppressed	NULL
to	NULL
a	NULL
level	NULL
of	NULL
40	NULL
+	NULL
10	NULL
%	NULL
of	NULL
pCAT-Basic	NULL
vector	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
decreased	NULL
further	NULL
to	NULL
15	NULL
+	NULL
10	NULL
%	NULL
(	NULL
+	NULL
S.D	NULL
.	NULL

from	NULL
four	NULL
experiments	NULL
)	NULL
of	NULL
pCAT-Basic	NULL
with	NULL
mutation	NULL
at	NULL
the	NULL
Spl/AP-2	NULL
site	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
tran	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Ecto-5'-NT	NULL
Promoter	NULL
Regulation	NULL
A	NULL
22709	NULL
gis	NULL
J	NULL
1	NULL
(	NULL
he-Â£	NULL
Tor	NULL
)	NULL
-Gantpu	NULL
a	NULL
)	NULL
-	NULL
(	NULL
one	NULL
Jara	NULL
pi	NULL
_	NULL
)	NULL
-	NULL
!	NULL

-	NULL
rees	NULL
am	NULL
CJ	NULL
Ecto-5'-NT	NULL
/	NULL
dCK	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

A	NULL
,	NULL
scheme	NULL
illustrating	NULL
the	NULL
chi-	NULL
Â£9	NULL
meric	NULL
dCK/ecto-5'-nucleotidase	NULL
promoter	NULL
.	NULL

en	NULL
B	NULL
,	NULL
activity	NULL
of	NULL
the	NULL
ecto-5'-nucleotidase	NULL
up-	NULL
E	NULL
stream	NULL
regulatory	NULL
region	NULL
in	NULL
the	NULL
context	NULL
of	NULL
%	NULL
50	NULL
dCK	NULL
core	NULL
promoter	NULL
in	NULL
several	NULL
human	NULL
cell	NULL
iS	NULL
]	NULL
lines	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

E	NULL
of	NULL
four	NULL
independent	NULL
determinations	NULL
done	NULL
g	NULL
40	NULL
in	NULL
duplicate	NULL
.	NULL

&	NULL
3	NULL
â¬	NULL
3	NULL
30	NULL
#	NULL
&	NULL
H	NULL
20	NULL
J	NULL
Â£	NULL
B	NULL
3	NULL
10	NULL
3	NULL
0	NULL
___..	NULL
Jurkat	NULL
scription	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
CRE	NULL
and	NULL
Sp/AP-2	NULL
sites	NULL
may	NULL
influence	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
.	NULL

Identification	NULL
of	NULL
Transcription	NULL
Factors	NULL
Binding	NULL
to	NULL
the	NULL
CRE	NULL
Site-We	NULL
next	NULL
employed	NULL
EMSAs	NULL
with	NULL
a	NULL
probe	NULL
encompassing	NULL
the	NULL
CRE	NULL
site	NULL
to	NULL
identify	NULL
cognate	NULL
transcription	NULL
factors	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

We	NULL
used	NULL
a	NULL
panel	NULL
of	NULL
antibodies	NULL
recognizing	NULL
members	NULL
of	NULL
the	NULL
CREB	NULL
and	NULL
ATF	NULL
family	NULL
of	NULL
proteins	NULL
and	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
transcription	NULL
factors	NULL
known	NULL
to	NULL
dimerize	NULL
with	NULL
members	NULL
of	NULL
the	NULL
CREB	NULL
family	NULL
.	NULL

Results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
demonstrate	NULL
that	NULL
antibodies	NULL
recognizing	NULL
CREB-1	NULL
,	NULL
CREB-2	NULL
,	NULL
CREM-1	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
c-Jun	NULL
were	NULL
not	NULL
able	NULL
to	NULL
supershift	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
,	NULL
whereas	NULL
antibodies	NULL
against	NULL
ATF-1	NULL
and	NULL
ATF-2	NULL
caused	NULL
distinctly	NULL
decreased	NULL
intensities	NULL
of	NULL
the	NULL
corresponding	NULL
lower	NULL
band	NULL
coincident	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
more	NULL
pronounced	NULL
(	NULL
ATF-1	NULL
)	NULL
or	NULL
a	NULL
new	NULL
(	NULL
ATF-2	NULL
)	NULL
upper	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A	NULL
and	NULL
D	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
supershifted	NULL
band	NULL
with	NULL
ATF-2-specific	NULL
antibody	NULL
was	NULL
similar	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
control	NULL
and	NULL
PMA-treated	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
there	NULL
was	NULL
a	NULL
somewhat	NULL
less	NULL
pronounced	NULL
decrease	NULL
in	NULL
ATF-2-specific	NULL
lower	NULL
complex	NULL
intensity	NULL
with	NULL
PMA-treated	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
polyclonal	NULL
antibody	NULL
against	NULL
ATF-2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Mutated	NULL
CRE	NULL
probe	NULL
did	NULL
not	NULL
produce	NULL
specific	NULL
band	NULL
shifts	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
ATF-1	NULL
and	NULL
ATF-2	NULL
or	NULL
closely	NULL
related	NULL
proteins	NULL
specifically	NULL
interact	NULL
with	NULL
the	NULL
CRE	NULL
site	NULL
in	NULL
the	NULL
ecto-5'-NT	NULL
core	NULL
promoter	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
Helia	NULL
nuclear	NULL
extract	NULL
,	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
strong	NULL
gel	NULL
shifts	NULL
,	NULL
none	NULL
of	NULL
the	NULL
specific	NULL
antibodies	NULL
described	NULL
above	NULL
resulted	NULL
in	NULL
a	NULL
supershifted	NULL
complexes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
PMA	NULL
on	NULL
Ecto-5'-NT	NULL
Promoter	NULL
Activity	NULL
in	NULL
Jurkat	NULL
T-cells-We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
induction	NULL
of	NULL
promyelo-cytic	NULL
HL6O	NULL
cells	NULL
to	NULL
differentiate	NULL
with	NULL
PMA	NULL
coincided	NULL
with	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
ecto-5'-NT	NULL
mRNA	NULL
level	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
CRE	NULL
site	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
PMA-responsive	NULL
element	NULL
through	NULL
the	NULL
modulation	NULL
of	NULL
the	NULL
ATF-2	NULL
transcription	NULL
factor	NULL
(	NULL
36	NULL
,	NULL
CO	NULL
Vector	NULL
C	NULL
Ecto-5'-NT	NULL
w	NULL
dCK	NULL
E	NULL
Ecto-5'-NT/dCK	NULL
K-T1	NULL
HeLa	NULL
37	NULL
)	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
possibility	NULL
that	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
PMA	NULL
might	NULL
increase	NULL
ecto-5'-NT	NULL
promoter	NULL
activity	NULL
through	NULL
activation	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
.	NULL

Results	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
show	NULL
that	NULL
activity	NULL
of	NULL
the	NULL
201-bp	NULL
promoter	NULL
fragment	NULL
was	NULL
induced	NULL
up	NULL
to	NULL
3-fold	NULL
by	NULL
a	NULL
20-h	NULL
treatment	NULL
with	NULL
20	NULL
nm	NULL
PMA	NULL
,	NULL
whereas	NULL
the	NULL
same	NULL
promoter	NULL
fragment	NULL
with	NULL
a	NULL
mutated	NULL
CRE	NULL
site	NULL
was	NULL
not	NULL
affected	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
969-bp	NULL
promoter	NULL
fragment	NULL
was	NULL
activated	NULL
approximately	NULL
17-fold	NULL
by	NULL
PMA	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
CRE	NULL
site	NULL
in	NULL
the	NULL
969-bp	NULL
fragment	NULL
increased	NULL
the	NULL
promoter	NULL
activity	NULL
as	NULL
described	NULL
previously	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
and	NULL
PMA	NULL
did	NULL
not	NULL
further	NULL
increase	NULL
this	NULL
activity	NULL
.	NULL

Mutational	NULL
Analysis	NULL
of	NULL
the	NULL
TCF-1/LEF-1	NULL
Transcription	NULL
Factor	NULL
Binding	NULL
Site-A	NULL
limited	NULL
number	NULL
of	NULL
promoters	NULL
or	NULL
enhancers	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
consensus	NULL
sites	NULL
for	NULL
the	NULL
developmentally	NULL
important	NULL
transcription	NULL
factors	NULL
TCF-1	NULL
and	NULL
LEF-1	NULL
.	NULL

Their	NULL
intrinsic	NULL
ability	NULL
to	NULL
bend	NULL
DNA	NULL
has	NULL
implicated	NULL
these	NULL
high	NULL
mobility	NULL
group	NULL
(	NULL
HMG	NULL
)	NULL
proteins	NULL
in	NULL
an	NULL
architectural	NULL
role	NULL
of	NULL
juxtaposing	NULL
distantly	NULL
located	NULL
transcription	NULL
factors	NULL
.	NULL

Recent	NULL
data	NULL
suggest	NULL
that	NULL
TCF-1	NULL
may	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
when	NULL
associated	NULL
with	NULL
Groucho	NULL
(	NULL
Grg	NULL
)	NULL
proteins	NULL
,	NULL
and	NULL
we	NULL
hypothesized	NULL
that	NULL
this	NULL
particular	NULL
function	NULL
could	NULL
explain	NULL
the	NULL
strong	NULL
negative	NULL
and	NULL
lymphocyte-specific	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
within	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
(	NULL
38	NULL
)	NULL
.	NULL

We	NULL
have	NULL
tested	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
TCF-1/LEF-1-mutated	NULL
969-bp	NULL
ecto-5'-NT	NULL
promoter	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
that	NULL
endog-enously	NULL
express	NULL
both	NULL
TCF-1	NULL
and	NULL
LEF-1	NULL
proteins	NULL
and	NULL
in	NULL
Hela	NULL
cells	NULL
that	NULL
lack	NULL
both	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
demonstrate	NULL
that	NULL
the	NULL
strong	NULL
negative	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
is	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
TCF/LEF	NULL
site	NULL
mutagenesis	NULL
.	NULL

The	NULL
same	NULL
mutations	NULL
,	NULL
however	NULL
,	NULL
completely	NULL
eliminated	NULL
gel	NULL
shifts	NULL
in	NULL
an	NULL
EMSA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
either	NULL
that	NULL
the	NULL
TCF-1/LEF-1	NULL
transcription	NULL
factors	NULL
do	NULL
not	NULL
contribute	NULL
or	NULL
that	NULL
elimination	NULL
of	NULL
this	NULL
site	NULL
alone	NULL
is	NULL
not	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
22710	NULL
sufficient	NULL
to	NULL
affect	NULL
the	NULL
negative	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
.	NULL

DISCUSSION	NULL
The	NULL
highly	NULL
variable	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
ecto-5'-NT	NULL
in	NULL
human	NULL
and	NULL
animal	NULL
tissues	NULL
and	NULL
cells	NULL
suggests	NULL
tissue-specific	NULL
mechanisms	NULL
controlling	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
enzyme	NULL
.	NULL

These	NULL
mechanisms	NULL
are	NULL
unknown	NULL
;	NULL
therefore	NULL
,	NULL
an	NULL
analysis	NULL
of	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
this	NULL
gene	NULL
was	NULL
undertaken	NULL
,	NULL
and	NULL
in	NULL
this	NULL
study	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
tissue-specific	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
ecto-5'-NT	NULL
gene	NULL
reveals	NULL
a	NULL
number	NULL
of	NULL
potential	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
820	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
within	NULL
the	NULL
first	NULL
exon	NULL
(	NULL
26	NULL
,	NULL
39	NULL
)	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
these	NULL
sites	NULL
were	NULL
concentrated	NULL
in	NULL
four	NULL
clusters	NULL
that	NULL
contain	NULL
a	NULL
number	NULL
of	NULL
lymphocyte-	NULL
and	NULL
mac-rophage-specific	NULL
,	NULL
developmentally	NULL
important	NULL
,	NULL
as	NULL
well	NULL
as	NULL
general	NULL
transcription	NULL
factor	NULL
binding	NULL
elements	NULL
.	NULL

The	NULL
occupancy	NULL
of	NULL
several	NULL
of	NULL
these	NULL
sites	NULL
was	NULL
confirmed	NULL
by	NULL
in	NULL
vitro	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
.	NULL

The	NULL
number	NULL
of	NULL
potential	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
suggests	NULL
that	NULL
there	NULL
might	NULL
be	NULL
a	NULL
high	NULL
level	NULL
of	NULL
complexity	NULL
in	NULL
the	NULL
interactions	NULL
between	NULL
binding	NULL
factors	NULL
,	NULL
especially	NULL
between	NULL
those	NULL
localized	NULL
immediately	NULL
5	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
and	NULL
those	NULL
further	NULL
upstream	NULL
.	NULL

Dele-	NULL
50.0	NULL
Â«	NULL
--	NULL
-	NULL
mme	NULL
45.0	NULL
M	NULL
Jurkat	NULL
40.0	NULL
4	NULL
H	NULL
HeLa	NULL
35.0	NULL
30.0	NULL
25.0	NULL
ln	NULL
I	NULL
Vector	NULL
201	NULL
bp	NULL
201	NULL
bp	NULL
201	NULL
bp	NULL
201	NULL
bp	NULL
970	NULL
bp	NULL
970	NULL
bp	NULL
970	NULL
bp	NULL
970	NULL
bp	NULL
Prom	NULL
.	NULL

Â§p1	NULL
(	NULL
)	NULL
AP-2	NULL
(	NULL
)	NULL
CREE	NULL
)	NULL
Prom	NULL
.	NULL

Spi	NULL
)	NULL
AP-2	NULL
(	NULL
)	NULL
CRE	NULL
(	NULL
)	NULL
Relative	NULL
CAT	NULL
activity	NULL
(	NULL
Fold	NULL
over	NULL
vector	NULL
alone	NULL
)	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
mutagenesis	NULL
of	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
201-	NULL
and	NULL
969-bp	NULL
promoters	NULL
on	NULL
ecto-5'-NT	NULL
promoter	NULL
activity	NULL
.	NULL

Transcription	NULL
factor	NULL
binding	NULL
sites	NULL
were	NULL
subjected	NULL
to	NULL
site-directed	NULL
mutagenesis	NULL
using	NULL
the	NULL
oligonucleotides	NULL
outlined	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
determinations	NULL
done	NULL
in	NULL
duplicate	NULL
.	NULL

A	NULL
B	NULL
Â«	NULL
CREB-1	NULL
aCREM-1	NULL
Â«	NULL
c-Fos	NULL
ac-Jun	NULL
Probe	NULL
No	NULL
antibody	NULL
f	NULL
0	NULL
``	NULL
P	NULL
CC	NULL
6	NULL
&	NULL
s	NULL
8	NULL
Mutated	NULL
probe	NULL
A	NULL
toa	NULL
8	NULL
4	NULL
<	NULL
-ATF-1	NULL
â	NULL
a	NULL
4	NULL
\l	NULL
)	NULL
us	NULL
Ecto-5'-NT	NULL
Promoter	NULL
Regulation	NULL
tional	NULL
analysis	NULL
of	NULL
the	NULL
5'-upstream	NULL
fragment	NULL
of	NULL
the	NULL
ecto-5'-NT	NULL
gene	NULL
confirmed	NULL
that	NULL
the	NULL
969-bp	NULL
promoter	NULL
fragment	NULL
mediates	NULL
cell-specific	NULL
regulation	NULL
of	NULL
expression	NULL
.	NULL

Deletion	NULL
of	NULL
768	NULL
bp	NULL
at	NULL
the	NULL
5'-end	NULL
of	NULL
this	NULL
fragment	NULL
eliminated	NULL
the	NULL
cell-specific	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
and	NULL
suggests	NULL
that	NULL
this	NULL
768-bp	NULL
fragment	NULL
contains	NULL
regulatory	NULL
elements	NULL
responsible	NULL
for	NULL
both	NULL
the	NULL
decreased	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
the	NULL
up-regulation	NULL
in	NULL
fibroblasts	NULL
.	NULL

Further	NULL
deletions	NULL
within	NULL
the	NULL
201-bp	NULL
fragment	NULL
decreased	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
therefore	NULL
,	NULL
we	NULL
designated	NULL
this	NULL
201-bp	NULL
region	NULL
as	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

The	NULL
dual	NULL
and	NULL
cell-specific	NULL
function	NULL
of	NULL
the	NULL
768-bp	NULL
upstream	NULL
regulatory	NULL
fragment	NULL
raises	NULL
important	NULL
questions	NULL
with	NULL
regard	NULL
to	NULL
whether	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
this	NULL
region	NULL
confer	NULL
this	NULL
specificity	NULL
as	NULL
well	NULL
as	NULL
how	NULL
the	NULL
core	NULL
promoter	NULL
activity	NULL
relates	NULL
to	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
.	NULL

The	NULL
cell-specific	NULL
regulation	NULL
of	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
may	NULL
be	NULL
conferred	NULL
by	NULL
proteins	NULL
binding	NULL
to	NULL
either	NULL
the	NULL
core	NULL
promoter	NULL
or	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
201-bp	NULL
core	NULL
promoter	NULL
region	NULL
led	NULL
to	NULL
several	NULL
important	NULL
observa-tions	NULL
.	NULL

First	NULL
,	NULL
while	NULL
single	NULL
mutations	NULL
at	NULL
the	NULL
Sp1	NULL
,	NULL
Spl/AP-2	NULL
,	NULL
and	NULL
CRE	NULL
binding	NULL
sites	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
201-bp	NULL
core	NULL
promoter	NULL
activity	NULL
,	NULL
mutation	NULL
at	NULL
the	NULL
CRE	NULL
had	NULL
a	NULL
profound	NULL
effect	NULL
on	NULL
the	NULL
promoter	NULL
activity	NULL
when	NULL
analyzed	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
969-bp	NULL
fragment	NULL
.	NULL

Elimination	NULL
of	NULL
the	NULL
CRE	NULL
site	NULL
dramatically	NULL
increased	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
,	NULL
suggesting	NULL
a	NULL
major	NULL
role	NULL
for	NULL
factors	NULL
binding	NULL
at	NULL
this	NULL
site	NULL
in	NULL
mediating	NULL
suppression	NULL
of	NULL
core	NULL
promoter	NULL
activity	NULL
by	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
.	NULL

In	NULL
addi-tion	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
SpL/AP-2	NULL
site	NULL
caused	NULL
a	NULL
further	NULL
decrease	NULL
in	NULL
the	NULL
low	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
969-bp	NULL
promoter	NULL
fragment	NULL
in	NULL
Jurkat	NULL
T-lymphocytes	NULL
and	NULL
a	NULL
significant	NULL
decrease	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

In	NULL
combination	NULL
,	NULL
these	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
regulatory	NULL
function	NULL
of	NULL
the	NULL
upstream	NULL
768-bp	NULL
fragment	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
transcription	NULL
factors	NULL
within	NULL
the	NULL
core	NULL
promoter	NULL
region	NULL
to	NULL
either	NULL
down-	NULL
or	NULL
up-regulate	NULL
the	NULL
rate	NULL
of	NULL
ecto-5'-NT	NULL
transcription	NULL
in	NULL
a	NULL
cell-	NULL
or	NULL
tissue-specific	NULL
manner	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
dCK	NULL
core	NULL
promoter	NULL
,	NULL
containing	NULL
a	NULL
Spl	NULL
and	NULL
E2F	NULL
(	NULL
half-site	NULL
)	NULL
transcription	NULL
factor	NULL
binding	NULL
site	NULL
,	NULL
was	NULL
also	NULL
inhibited	NULL
by	NULL
the	NULL
ecto-5'-NT	NULL
upstream	NULL
regulatory	NULL
region	NULL
,	NULL
suggests	NULL
that	NULL
the	NULL
CRE	NULL
site	NULL
,	NULL
while	NULL
essential	NULL
for	NULL
the	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
,	NULL
may	NULL
not	NULL
be	NULL
absolutely	NULL
required	NULL
for	NULL
transcriptional	NULL
repression	NULL
mediated	NULL
by	NULL
this	NULL
region	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
abrogation	NULL
of	NULL
PMA	NULL
responsiveness	NULL
by	NULL
mutation	NULL
of	NULL
the	NULL
CRE	NULL
site	NULL
strongly	NULL
supports	NULL
an	NULL
important	NULL
role	NULL
for	NULL
CRE-binding	NULL
proteins	NULL
in	NULL
regulating	NULL
ecto-5'-NT	NULL
activity	NULL
.	NULL

The	NULL
latter	NULL
conclusion	NULL
is	NULL
consistent	NULL
(	NULL
@	NULL
]	NULL
O	NULL
Control	NULL
__	NULL
PMA	NULL
S	NULL
|	NULL
compnmmmmmms	NULL
5g	NULL
0	NULL
f	NULL
.	NULL

i	NULL
a	NULL
.	NULL

Â§	NULL
f	NULL
â	NULL
EE	NULL
â	NULL
F	NULL
--	NULL
a.	NULL
P	NULL
Â§	NULL
5	NULL
4	NULL
i	NULL
Â©	NULL
=	NULL
=	NULL
so	NULL
=	NULL
s	NULL
T	NULL
&	NULL
2	NULL
|	NULL
Iii	NULL
liq-ATF-z	NULL
Heit	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

EMSA	NULL
of	NULL
the	NULL
CRE	NULL
binding	NULL
site	NULL
with	NULL
Jurkat	NULL
T-cell	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibodies	NULL
against	NULL
members	NULL
of	NULL
the	NULL
CREB	NULL
and	NULL
ATF	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

A	NULL
,	NULL
incubations	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
(	NULL
50	NULL
mM	NULL
KCl	NULL
)	NULL
.	NULL

B	NULL
,	NULL
incubations	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
70	NULL
mM	NULL
KCl	NULL
to	NULL
reduce	NULL
nonspecific	NULL
interactions	NULL
.	NULL

Cold	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
mutated	NULL
CRE	NULL
site	NULL
was	NULL
added	NULL
as	NULL
a	NULL
competitor	NULL
at	NULL
a	NULL
1000-fold	NULL
excess	NULL
in	NULL
the	NULL
last	NULL
lane	NULL
.	NULL

C	NULL
,	NULL
comparison	NULL
of	NULL
gel	NULL
shift	NULL
patterns	NULL
of	NULL
mutated	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
and	NULL
wild-type	NULL
CRE	NULL
probes	NULL
.	NULL

D	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
ATF-2	NULL
antibody	NULL
on	NULL
the	NULL
gel	NULL
shift	NULL
pattern	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
PMA	NULL
treatment	NULL
(	NULL
20	NULL
ng/ml	NULL
for	NULL
24	NULL
h	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Ecto-5'-NT	NULL
Promoter	NULL
Regulation	NULL
45	NULL
40	NULL
|	NULL
35	NULL
|	NULL
30	NULL
|	NULL
25	NULL
|	NULL
20	NULL
15	NULL
10	NULL
4	NULL
LJ	NULL
RH	NULL
an	NULL
Â»	NULL
Vector	NULL
Vector	NULL
201	NULL
bp	NULL
201	NULL
bp	NULL
201	NULL
bp	NULL
201	NULL
bp	NULL
969	NULL
bp	NULL
969	NULL
bp	NULL
969	NULL
bp	NULL
969	NULL
bp	NULL
+PMA	NULL
wit	NULL
wit	NULL
CRE	NULL
(	NULL
-	NULL
)	NULL
CRE	NULL
(	NULL
Â»	NULL
)	NULL
wit	NULL
wit	NULL
CRE	NULL
(	NULL
-	NULL
)	NULL
+PMA	NULL
+PMA	NULL
+PMA	NULL
+PMA	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PMA	NULL
on	NULL
the	NULL
native	NULL
and	NULL
CRE-mutated	NULL
201-and	NULL
969-bp	NULL
promoter	NULL
fragments	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
.	NULL

Values	NULL
repre-	NULL
sent	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
determinations	NULL
done	NULL
in	NULL
duplicate	NULL
.	NULL

Relative	NULL
CAT	NULL
activity	NULL
(	NULL
Fold	NULL
over	NULL
vector	NULL
alone	NULL
)	NULL
Â©	NULL
with	NULL
reports	NULL
that	NULL
describe	NULL
the	NULL
CRE	NULL
site	NULL
as	NULL
a	NULL
PMA-responsive	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
PMA-induced	NULL
ecto-5'-NT	NULL
promoter	NULL
activation	NULL
is	NULL
unknown	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
,	NULL
however	NULL
,	NULL
that	NULL
as	NULL
reported	NULL
previously	NULL
(	NULL
36	NULL
)	NULL
,	NULL
PMA	NULL
may	NULL
induce	NULL
changes	NULL
in	NULL
the	NULL
composition	NULL
of	NULL
protein	NULL
complexes	NULL
binding	NULL
to	NULL
the	NULL
CRE	NULL
site	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
not	NULL
seen	NULL
a	NULL
significant	NULL
change	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
supershifts	NULL
with	NULL
ATF-2	NULL
antibodies	NULL
in	NULL
EMSA	NULL
after	NULL
pre-treatment	NULL
of	NULL
cells	NULL
with	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
)	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
lower	NULL
band	NULL
did	NULL
not	NULL
decrease	NULL
as	NULL
strongly	NULL
as	NULL
in	NULL
the	NULL
control	NULL
,	NULL
suggesting	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
increased	NULL
amount	NULL
of	NULL
other	NULL
protein	NULL
components	NULL
in	NULL
this	NULL
complex	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
this	NULL
component	NULL
and	NULL
its	NULL
relevance	NULL
to	NULL
the	NULL
increased	NULL
promoter	NULL
activity	NULL
after	NULL
treatment	NULL
with	NULL
PMA	NULL
remain	NULL
to	NULL
be	NULL
established	NULL
.	NULL

The	NULL
ecto-5'-NT	NULL
CRE	NULL
element	NULL
(	NULL
TGACGTCG	NULL
)	NULL
differs	NULL
from	NULL
the	NULL
consensus	NULL
CRE	NULL
palindrome	NULL
by	NULL
one	NULL
base	NULL
(	NULL
underlined	NULL
)	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
single	NULL
base	NULL
changes	NULL
in	NULL
this	NULL
cis-acting	NULL
DNA	NULL
element	NULL
may	NULL
dramatically	NULL
influence	NULL
the	NULL
binding	NULL
properties	NULL
and	NULL
function	NULL
of	NULL
this	NULL
site	NULL
(	NULL
36	NULL
,	NULL
40	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
,	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
several	NULL
members	NULL
of	NULL
the	NULL
CREB/	NULL
ATF	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
Hela	NULL
cell	NULL
lines	NULL
,	NULL
only	NULL
antibodies	NULL
against	NULL
ATF-1	NULL
and	NULL
ATF-2	NULL
interacted	NULL
with	NULL
protein	NULL
complexes	NULL
in	NULL
EMSAs	NULL
using	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
.	NULL

As	NULL
a	NULL
result	NULL
of	NULL
these	NULL
interactions	NULL
,	NULL
two	NULL
changes	NULL
were	NULL
observed	NULL
:	NULL
(	NULL
@	NULL
)	NULL
decreased	NULL
intensities	NULL
of	NULL
the	NULL
initial	NULL
ATF-1	NULL
and	NULL
ATF-2	NULL
(	NULL
lower	NULL
band	NULL
)	NULL
complexes	NULL
and	NULL
(	NULL
b	NULL
)	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
corresponding	NULL
supershifts	NULL
.	NULL

The	NULL
existence	NULL
of	NULL
two	NULL
distinct	NULL
gel	NULL
shifts	NULL
,	NULL
each	NULL
independently	NULL
interacting	NULL
with	NULL
ATF-1	NULL
and	NULL
ATF-2	NULL
antibodies	NULL
,	NULL
suggests	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
different	NULL
species	NULL
of	NULL
protein	NULL
complexes	NULL
at	NULL
the	NULL
CRE	NULL
site	NULL
.	NULL

The	NULL
absence	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
supershifted	NULL
bands	NULL
of	NULL
these	NULL
and	NULL
several	NULL
other	NULL
known	NULL
CREB/ATF	NULL
family	NULL
members	NULL
as	NULL
well	NULL
as	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
proteins	NULL
,	NULL
suggests	NULL
that	NULL
a	NULL
different	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
in	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
.	NULL

These	NULL
observations	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
higher	NULL
basal	NULL
promoter	NULL
activity	NULL
and	NULL
endogenous	NULL
ecto-5'-NT	NULL
mRNA	NULL
expression	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
would	NULL
suggest	NULL
that	NULL
ATF-1	NULL
and	NULL
ATF-2	NULL
transcription	NULL
factors	NULL
mediate	NULL
low	NULL
promoter	NULL
activity	NULL
in	NULL
lymphocytes	NULL
.	NULL

Whether	NULL
both	NULL
have	NULL
the	NULL
same	NULL
potency	NULL
in	NULL
suppressing	NULL
the	NULL
ecto-5	NULL
``	NULL
-NT	NULL
promoter	NULL
activity	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
SpUAP-2	NULL
site	NULL
increased	NULL
the	NULL
suppressive	NULL
activity	NULL
of	NULL
the	NULL
969-bp	NULL
promoter	NULL
fragment	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
,	NULL
interestingly	NULL
,	NULL
also	NULL
uncovered	NULL
the	NULL
potential	NULL
for	NULL
the	NULL
suppression	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
the	NULL
intrinsic	NULL
ability	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
to	NULL
inhibit	NULL
core	NULL
promoter	NULL
activity	NULL
may	NULL
represent	NULL
a	NULL
more	NULL
general	NULL
property	NULL
of	NULL
this	NULL
fragment	NULL
and	NULL
that	NULL
the	NULL
tissue-	NULL
and	NULL
cell-specific	NULL
up-	NULL
and	NULL
down-regulation	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
may	NULL
be	NULL
more	NULL
specifically	NULL
mediated	NULL
by	NULL
factors	NULL
binding	NULL
to	NULL
CRE	NULL
and	NULL
SpUAP-2	NULL
sites	NULL
.	NULL

In	NULL
that	NULL
respect	NULL
,	NULL
and	NULL
due	NULL
perhaps	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
NFAT	NULL
,	NULL
TCF/LEF	NULL
,	NULL
Ets	NULL
,	NULL
and	NULL
an	NULL
un-	NULL
20	NULL
;	NULL
z	NULL
C	NULL
O	NULL
Vector	NULL
6	NULL
is	NULL
E	NULL
Â©1201	NULL
bp	NULL
Core	NULL
promoter	NULL
9	NULL
16	NULL
â	NULL
g	NULL
â	NULL
Â©969	NULL
bp	NULL
Promoter	NULL
>	NULL
5	NULL
14	NULL
M969	NULL
bp	NULL
Promoter	NULL
TCF/LEF	NULL
(	NULL
-	NULL
)	NULL
3	NULL
as	NULL
|	NULL
S	NULL
2	NULL
|	NULL
i	NULL
,	NULL
10	NULL
.	NULL

â¬	NULL
>	NULL
8	NULL
4	NULL
&	NULL
2	NULL
6	NULL
o	NULL
o	NULL
4	NULL
&	NULL
5	NULL
2	NULL
|	NULL
Â®	NULL
I	NULL
&	NULL
,	NULL
o	NULL
-	NULL
Lams	NULL
.	NULL

Soo	NULL
Jurkat	NULL
HeLa	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
mutation	NULL
of	NULL
the	NULL
TCF-1/LEF-1	NULL
transcription	NULL
factor	NULL
binding	NULL
site	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
determinations	NULL
done	NULL
in	NULL
duplicate	NULL
.	NULL

known	NULL
transcription	NULL
factor	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
,	NULL
the	NULL
overall	NULL
suppressive	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
is	NULL
inherently	NULL
more	NULL
potent	NULL
in	NULL
Jurkat	NULL
than	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

According	NULL
to	NULL
this	NULL
model	NULL
,	NULL
the	NULL
up-regulation	NULL
of	NULL
promoter	NULL
activity	NULL
in	NULL
tissues	NULL
that	NULL
express	NULL
low	NULL
to	NULL
intermediate	NULL
levels	NULL
of	NULL
ecto-5'-NT	NULL
would	NULL
be	NULL
achieved	NULL
primarily	NULL
by	NULL
derepression	NULL
.	NULL

Thus	NULL
,	NULL
increased	NULL
ATF-1	NULL
and/or	NULL
ATF-2	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
CRE	NULL
site	NULL
would	NULL
facilitate	NULL
repression	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
,	NULL
whereas	NULL
increased	NULL
binding	NULL
to	NULL
the	NULL
SpAP-2	NULL
site	NULL
would	NULL
facilitate	NULL
derepression	NULL
.	NULL

The	NULL
nature	NULL
and	NULL
specific	NULL
mechanism	NULL
of	NULL
the	NULL
negative	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
will	NULL
be	NULL
a	NULL
subject	NULL
for	NULL
future	NULL
study	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
several	NULL
regulatory	NULL
elements	NULL
that	NULL
may	NULL
potentially	NULL
contribute	NULL
to	NULL
the	NULL
repressive	NULL
effect	NULL
.	NULL

One	NULL
possible	NULL
candidate	NULL
is	NULL
transcription	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
NRE-2a/2b	NULL
negative	NULL
regulatory	NULL
element	NULL
(	NULL
35	NULL
,	NULL
41	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
specific	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
established	NULL
.	NULL

Other	NULL
candidates	NULL
,	NULL
specific	NULL
for	NULL
lymphocytes	NULL
and	NULL
of	NULL
potential	NULL
importance	NULL
during	NULL
development	NULL
,	NULL
are	NULL
the	NULL
TCF-1	NULL
and	NULL
LEF-1	NULL
transcription	NULL
factors	NULL
.	NULL

These	NULL
proteins	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
transcriptional	NULL
repressor	NULL
Groucho	NULL
(	NULL
38	NULL
)	NULL
and	NULL
to	NULL
have	NULL
an	NULL
important	NULL
architectural	NULL
function	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
TCRa	NULL
enhancer	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

However	NULL
,	NULL
since	NULL
mutation	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
TCF/LEF	NULL
did	NULL
not	NULL
produce	NULL
a	NULL
noticeable	NULL
change	NULL
in	NULL
the	NULL
function	NULL
of	NULL
this	NULL
768-bp	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
several	NULL
interacting	NULL
transcription	NULL
factors	NULL
might	NULL
form	NULL
,	NULL
in	NULL
a	NULL
cooperative	NULL
manner	NULL
,	NULL
a	NULL
functional	NULL
higher	NULL
order	NULL
nucleoprotein	NULL
complex	NULL
in	NULL
lymphocytes	NULL
.	NULL

This	NULL
possibility	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
our	NULL
finding	NULL
that	NULL
the	NULL
768-bp	NULL
fragment	NULL
was	NULL
able	NULL
to	NULL
function	NULL
independently	NULL
in	NULL
the	NULL
heterologous	NULL
promoter	NULL
system	NULL
with	NULL
the	NULL
244-bp	NULL
dCK	NULL
promoter	NULL
.	NULL

Specific	NULL
cooperation	NULL
among	NULL
Ets	NULL
,	NULL
LEF-1	NULL
,	NULL
AML	NULL
,	NULL
and	NULL
CRE	NULL
transcription	NULL
factors	NULL
has	NULL
already	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
the	NULL
function	NULL
of	NULL
the	NULL
TCRa	NULL
enhancer	NULL
(	NULL
42-44	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
we	NULL
have	NULL
noted	NULL
that	NULL
the	NULL
spatial	NULL
alignment	NULL
of	NULL
GATA	NULL
,	NULL
Ets	NULL
,	NULL
TCFE-U/LEF-1	NULL
,	NULL
and	NULL
CRE	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
TCRa	NULL
enhancer	NULL
closely	NULL
resembles	NULL
their	NULL
location	NULL
in	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
(	NULL
45	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
arrangement	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
was	NULL
also	NULL
found	NULL
in	NULL
TCRB	NULL
and	NULL
TCRS8	NULL
,	NULL
CD8	NULL
,	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancers	NULL
(	NULL
46-48	NULL
)	NULL
.	NULL

Whether	NULL
this	NULL
structural	NULL
alignment	NULL
,	NULL
with	NULL
an	NULL
invariably	NULL
central	NULL
position	NULL
of	NULL
the	NULL
relatively	NULL
rare	NULL
TCF/LEF	NULL
site	NULL
,	NULL
carries	NULL
out	NULL
a	NULL
specific	NULL
function	NULL
common	NULL
to	NULL
these	NULL
enhancers	NULL
and	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

TCF/LEF	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
nuclear	NULL
targets	NULL
for	NULL
Wut	NULL
signaling	NULL
(	NULL
49-51	NULL
)	NULL
,	NULL
and	NULL
our	NULL
current	NULL
efforts	NULL
are	NULL
aimed	NULL
at	NULL
establishing	NULL
whether	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
is	NULL
a	NULL
target	NULL
for	NULL
this	NULL
evolutionarily	NULL
conserved	NULL
and	NULL
developmentally	NULL
important	NULL
signaling	NULL
pathway	NULL
.	NULL

Since	NULL
only	NULL
a	NULL
single	NULL
gene	NULL
target	NULL
for	NULL
Wnt	NULL
signaling	NULL
has	NULL
been	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
22712	NULL
identified	NULL
in	NULL
mammals	NULL
to	NULL
date	NULL
(	NULL
52	NULL
)	NULL
,	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
would	NULL
offer	NULL
an	NULL
excellent	NULL
model	NULL
to	NULL
study	NULL
the	NULL
mechanisms	NULL
of	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
this	NULL
pathway	NULL
.	NULL

Thus	NULL
,	NULL
further	NULL
delineation	NULL
of	NULL
the	NULL
specific	NULL
interactions	NULL
involving	NULL
a	NULL
higher	NULL
order	NULL
nucleoprotein	NULL
complex	NULL
of	NULL
the	NULL
ecto-5'-NT	NULL
promoter	NULL
may	NULL
not	NULL
only	NULL
enhance	NULL
our	NULL
understanding	NULL
of	NULL
how	NULL
these	NULL
signaling	NULL
pathways	NULL
modulate	NULL
the	NULL
transcription	NULL
of	NULL
ecto-5'-NT	NULL
gene	NULL
but	NULL
will	NULL
also	NULL
lead	NULL
to	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
its	NULL
function	NULL
during	NULL
development	NULL
and	NULL
transformation	NULL
.	NULL

to	NULL
bo	NULL
o	NULL
o	NULL
go	NULL
i	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

18	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

REFERENCES	NULL
.	NULL

Belardinelli	NULL
,	NULL
L.	NULL
,	NULL
Linden	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Berne	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Prog	NULL
.	NULL

Cardiovasc	NULL
.	NULL

Dis	NULL
.	NULL

82	NULL
,	NULL
73-97	NULL
.	NULL

Ely	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
and	NULL
Berne	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Circulation	NULL
85	NULL
,	NULL
893-904	NULL
.	NULL

Cronstein	NULL
,	NULL
B.	NULL
N.	NULL
,	NULL
Levin	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
Belanoff	NULL
,	NULL
J.	NULL
,	NULL
Weissmann	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Hirschhorn	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

78	NULL
,	NULL
760-770	NULL
.	NULL

MacKenzie	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Hoskin	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Bly	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

54	NULL
,	NULL
3521-3526	NULL
.	NULL

Cronstein	NULL
,	NULL
B.	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
J	NULL
.	NULL

Invest	NULL
.	NULL

Med	NULL
.	NULL

48	NULL
,	NULL
50-57	NULL
.	NULL

Huang	NULL
,	NULL
S.	NULL
,	NULL
Apasov	NULL
,	NULL
S.	NULL
,	NULL
Koshiba	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sitkovsky	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Blood	NULL
90	NULL
,	NULL
1600-1610	NULL
.	NULL

Meininger	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Granger	NULL
,	NULL
H.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

258	NULL
,	NULL
H198-H206	NULL
.	NULL

Khoo	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
Ho	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Chhatwal	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
Chan	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Ngoi	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
and	NULL
Moochhala	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Cancer	NULL
Left	NULL
.	NULL

106	NULL
,	NULL
17-21	NULL
.	NULL

Williams	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Manzer	NULL
,	NULL
A.	NULL
,	NULL
Blay	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Hoskin	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1997	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

281	NULL
,	NULL
264-269	NULL
Gutensohn	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Thiel	NULL
,	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Cancer	NULL
66	NULL
,	NULL
1755-1758	NULL
Canbolat	NULL
,	NULL
O.	NULL
,	NULL
Durak	NULL
,	NULL
I.	NULL
,	NULL
Cetin	NULL
,	NULL
R.	NULL
,	NULL
Kavutcu	NULL
,	NULL
M.	NULL
,	NULL
Demirci	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Ozturk	NULL
,	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Breast	NULL
Cancer	NULL
.	NULL

Res	NULL
.	NULL

Treat	NULL
.	NULL

87	NULL
,	NULL
189-198	NULL
Durak	NULL
,	NULL
L.	NULL
,	NULL
Perk	NULL
,	NULL
H.	NULL
,	NULL
Kavutcu	NULL
,	NULL
M.	NULL
,	NULL
Canbolat	NULL
,	NULL
O.	NULL
,	NULL
Akyol	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Beduk	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Free	NULL
Radical	NULL
Biol	NULL
.	NULL

Med	NULL
.	NULL

16	NULL
,	NULL
825-831	NULL
Flocke	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Mannbherz	NULL
,	NULL
H.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1076	NULL
,	NULL
273-281	NULL
Gutensohn	NULL
,	NULL
W.	NULL
,	NULL
Thiel	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Emmerich	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Klin	NULL
.	NULL

Wochenschr	NULL
.	NULL

61	NULL
,	NULL
57-62	NULL
Fukunaga	NULL
,	NULL
Y.	NULL
,	NULL
Evans	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Ueda	NULL
,	NULL
Y.	NULL
,	NULL
Tamura	NULL
,	NULL
K.	NULL
,	NULL
Takakuwa	NULL
,	NULL
T.	NULL
,	NULL
Gebhard	NULL
,	NULL
D.	NULL
,	NULL
Allopenna	NULL
,	NULL
J.	NULL
,	NULL
Demaria	NULL
,	NULL
S.	NULL
,	NULL
Clarkson	NULL
,	NULL
B.	NULL
,	NULL
Thompson	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
Safai	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
2486-2492	NULL
Clark	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
and	NULL
Docherty	NULL
,	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

296	NULL
,	NULL
521-541	NULL
Prager	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
and	NULL
Kanar	NULL
,	NULL
M.	NULL
C.	NULL
(	NULL
1984	NULL
)	NULL
Cancer	NULL
Left	NULL
.	NULL

24	NULL
,	NULL
81-88	NULL
Thompson	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
Saxon	NULL
,	NULL
A.	NULL
,	NULL
O'Connor	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Fox	NULL
,	NULL
R.	NULL
I	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

71	NULL
,	NULL
892-899	NULL
Thompson	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
Ruedi	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
O'Connor	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Bastia	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

187	NULL
,	NULL
2496-2500	NULL
Spychala	NULL
,	NULL
J.	NULL
,	NULL
Mitchell	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
and	NULL
Barankiewicz	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
4947-4952	NULL
Quagliata	NULL
,	NULL
F.	NULL
,	NULL
Faig	NULL
,	NULL
D.	NULL
,	NULL
Conklyn	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Silber	NULL
,	NULL
R.	NULL
(	NULL
1974	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

34	NULL
,	NULL
3197-3202	NULL
Salazar-Gonzales	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Moody	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Giorgi	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
Martinez-Maza	NULL
,	NULL
O.	NULL
,	NULL
Mitsuyasu	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
and	NULL
Fahey	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

185	NULL
,	NULL
1778-1787	NULL
Smith	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Morgan	NULL
,	NULL
R.	NULL
,	NULL
Link	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
McFall	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Hecht	NULL
,	NULL
F.	NULL
(	NULL
1986	NULL
)	NULL
Blood	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

Ecto-5'-NT	NULL
Promoter	NULL
Regulation	NULL
67	NULL
,	NULL
650-659	NULL
Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
Misumi	NULL
,	NULL
Y.	NULL
,	NULL
Ogata	NULL
,	NULL
S.	NULL
,	NULL
Hirose	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Ikehara	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
2178-2183	NULL
Spychala	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Mitchell	NULL
,	NULL
B.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Adv	NULL
.	NULL

Exp	NULL
.	NULL

Med	NULL
.	NULL

Biol	NULL
.	NULL

870	NULL
,	NULL
683-687	NULL
Chen	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Johnson	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
Vetter	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Mitchell	NULL
,	NULL
B.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

95	NULL
,	NULL
1660-1668	NULL
Bradford	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1976	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
,	NULL
248-254	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Blake	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
Azizkhan	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
4994-5002	NULL
Zimmermann	NULL
,	NULL
A.	NULL
,	NULL
Gu	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Spychala	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Mitchell	NULL
,	NULL
B.	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Adv	NULL
.	NULL

Enzyme	NULL
Regul	NULL
.	NULL

86	NULL
,	NULL
15-84	NULL
Waterman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Jones	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

2	NULL
,	NULL
621-636	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
,	NULL
Oosterwegel	NULL
,	NULL
M.	NULL
,	NULL
Dooijes	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Clevers	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
123-132	NULL
Giese	NULL
,	NULL
K.	NULL
,	NULL
Amsterdam	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Grossched1	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
2567-2578	NULL
Oh	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
Neurath	NULL
,	NULL
M.	NULL
,	NULL
Cho	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Semere	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Metcalfe	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

828	NULL
,	NULL
511-519	NULL
Costa	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Medcalf	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

287	NULL
,	NULL
582-538	NULL
Jiang	NULL
,	NULL
K.	NULL
,	NULL
Spyrou	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Rokaeus	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

246	NULL
,	NULL
192-198	NULL
Levanon	NULL
,	NULL
D.	NULL
,	NULL
Goldstein	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Bernstein	NULL
,	NULL
Y.	NULL
,	NULL
Tang	NULL
,	NULL
H.	NULL
,	NULL
Goldenberg	NULL
,	NULL
D.	NULL
,	NULL
Stifani	NULL
,	NULL
S.	NULL
,	NULL
Paroush	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Groner	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

95	NULL
,	NULL
11590-11595	NULL
Hansen	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Resta	NULL
,	NULL
R.	NULL
,	NULL
Webb	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
L.	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

167	NULL
,	NULL
307-312	NULL
Holmberg	NULL
,	NULL
M.	NULL
,	NULL
Leonardson	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Ny	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

281	NULL
,	NULL
466-474	NULL
Ogbourne	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Antalis	NULL
,	NULL
T.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

881	NULL
,	NULL
1-14	NULL
Giese	NULL
,	NULL
K.	NULL
,	NULL
Kingsley	NULL
,	NULL
C.	NULL
,	NULL
Kirshner	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Grosschedl	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
995-1008	NULL
Mayall	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Sheridan	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Montminy	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Jones	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

11	NULL
,	NULL
887-99	NULL
Hernandez-Munain	NULL
,	NULL
C.	NULL
,	NULL
Roberts	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Krangel	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
32235-3233	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11	NULL
,	NULL
539-570	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

6	NULL
,	NULL
231-237	NULL
Hambor	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Mennone	NULL
,	NULL
J.	NULL
,	NULL
Coon	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Hanke	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Kavathas	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
7056-7070	NULL
Sheridan	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Sheline	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
Cannon	NULL
,	NULL
K.	NULL
,	NULL
Voz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Pazin	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
Jones	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
2090-2104	NULL
Behrens	NULL
,	NULL
J.	NULL
,	NULL
von	NULL
Kries	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Kuhl	NULL
,	NULL
M.	NULL
,	NULL
Bruhn	NULL
,	NULL
L.	NULL
,	NULL
Wedlich	NULL
,	NULL
D.	NULL
,	NULL
Grossched1	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Birchmeier	NULL
,	NULL
W.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
382	NULL
,	NULL
688-642	NULL
Huber	NULL
,	NULL
O.	NULL
,	NULL
Korn	NULL
,	NULL
R.	NULL
,	NULL
McLaughlin	NULL
,	NULL
J.	NULL
,	NULL
Ohsugi	NULL
,	NULL
M.	NULL
,	NULL
Herrmann	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
and	NULL
Kemler	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Mech	NULL
.	NULL

Dev	NULL
.	NULL

59	NULL
,	NULL
3-10	NULL
Molenaar	NULL
,	NULL
M.	NULL
,	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
,	NULL
Oosterwegel	NULL
,	NULL
M.	NULL
,	NULL
Peterson-Maduro	NULL
,	NULL
J.	NULL
,	NULL
Godsave	NULL
,	NULL
S.	NULL
,	NULL
Korinek	NULL
,	NULL
V.	NULL
,	NULL
Roose	NULL
,	NULL
J.	NULL
,	NULL
Destree	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Clevers	NULL
,	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
86	NULL
,	NULL
391-399	NULL
He	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Sparks	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Rago	NULL
,	NULL
C.	NULL
,	NULL
Hermeking	NULL
,	NULL
H.	NULL
,	NULL
Zawel	NULL
,	NULL
L.	NULL
,	NULL
da	NULL
Costa	NULL
,	NULL
L.	NULL
T.	NULL
,	NULL
Morin	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Vogelstein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Kinzler	NULL
,	NULL
K.	NULL
W.	NULL
(	NULL
1998	NULL
)	NULL
Science	NULL
281	NULL
,	NULL
1509-1512	NULL
Costa	NULL
,	NULL
M.	NULL
,	NULL
Shen	NULL
,	NULL
Y.	NULL
,	NULL
Maurer	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Medcalf	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

258	NULL
,	NULL
123-131	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Tissue-specific	NULL
Regulation	NULL
of	NULL
the	NULL
Ecto-5'-nucleotidase	NULL
Promoter	NULL
:	NULL
ROLE	NULL
OF	NULL
THE	NULL
cAMP	NULL
RESPONSE	NULL
ELEMENT	NULL
SITE	NULL
IN	NULL
MEDIATING	NULL
REPRESSION	NULL
BY	NULL
THE	NULL
UPSTREAM	NULL
REGULATORY	NULL
REGION	NULL
Jozef	NULL
Spychala	NULL
,	NULL
Albert	NULL
G.	NULL
Zimmermann	NULL
and	NULL
Beverly	NULL
S.	NULL
Mitchell	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1999	NULL
,	NULL
274:22705-22712.	NULL
doi	NULL
:	NULL
10.1074/jb0.274.32.22705	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/274/32/22705	NULL
Alerts	NULL
:	NULL
Â«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
Â«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
53	NULL
references	NULL
,	NULL
22	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

